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VABSTRACT
1. A multi-disciplinary approach was adopted in which biochemical, 
biophysical and pharmacological techniques were used to further 
characterise the nature of the abnormality predisposing to malignant 
hyperpyrexia (MH).
2. Chemical characteristics of density gradient fractionated skeletal 
muscle microsomal membrane preparations from both normal and malignant 
hyperpyrexic swine failed to reveal consistent differences in either lipid 
or protein content.
3. *H NMR studies of the effects of halothane on normal and MH microsomal 
membrane preparations indicated that the anaesthetic '’fluidises" such 
membranes, but these effects were similar in both muscle types.
4. Halothane-membrane interactions were also studied in a model membrane 
system using 19F and 31P NMR spectroscopy. Such an approach permitted
the monitoring of halothane and phospholipid environments in the same sample.
5. The temperature dependence of halothane-, caffeine-, succinylcholine- 
and KCl-induced contractures was investigated in isolated normal and MH 
skeletal muscle preparations. Drug-induced hypercontractility was 
abolished at 25°C suggesting that the abnormal drug-induced release of 
calcium which occurs at 37°C is blocked at 25°C.
6. High concentrations (> 200 yM) of the calcium ion antagonist TMB-8 
contracted MH skeletal muscle preparations in vitro, and this response 
was abolished by E-C uncoupling treatments (i.e. dantrolene sodium, D20 - 
Ringer or glycerol-induced detubulation).
vi
7. In MH porcine skeletal muscle low concentrations of TMB-8 (100 yM) 
potentiated contractile responses to halothane, caffeine and 
succinylcholine but partially blocked KCl-induced contractures. The 
qualitative similarity between the potentiating effects of TMB-8 on 
halothane-, caffeine- and succinylcholine-induced contractures suggests 
a common site of action for these drugs and it is proposed that this 
site is in fact the triad.
8. 3% halothane, 2 mM caffeine, 1 mM succinylcholine and 80 mM KC1 
failed to contract normal porcine muscle either in the absence or 
presence of TMB-8 (100 yM to 1 mM) or over the 20°C to 45°C temperature 
range.
9. Platelet aggregation was abnormal in a number of MH susceptible 
individuals suggesting that in at least some individuals susceptibility 
to MH reflects a generalised defect in a variety of cell types. The 
variable occurrence of such platelet abnormalities suggests that platelet 
function tests should not be used in isolation when attempting to identify 
MH susceptibility.
10. The relevance of these studies to the understanding of the underlying 
abnormality predisposing to Mil is discussed.
vii
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1CHAPTER 1
GENERAL INTRODUCTION
1.1 INTRODUCTION
Since the first description of malignant hyperpyrexia (MH) by 
Denborough and Lovell in 1960, the occurrence of familial anaesthetic 
deaths has received considerable attention. The demonstration of the 
hereditary nature of the syndrome and the concurrent elucidation of the 
genetic pattern of inheritance (Denborough et al. , 1962) confirmed the 
significance of the initial report. Subsequent work in Canada (Britt and 
Kalow, 1970), in England (Ellis et al. , 1972) and in South Africa (Isaacs 
and Barlow, 1970) has documented its global distribution.
The syndrome occurs in susceptible individuals on exposure to an 
appropriate trigger, with the general anaesthetic halothane and the muscle 
relaxant succinylcholine being the most widely incriminated agents in 
clinical practice (Britt et al., 1977). The usual rate of occurrence is 
between 1:10,000 to 1:15,000 (Williams, 1976) and once initiated mortality 
rates may be as high as 70% (Britt and Kalow, 1970). The clinical features 
of the syndrome consist of (1) tachycardia; (2) pronounced metabolic 
acidosis; (3) alterations in serum electrolyte balance; (4) muscular 
rigidity; (5) hyperpyrexia; (6) vascular constriction and (7) an 
elevation in body core temperature.
A relationship between MH and an underlying disease of the skeletal 
musculature was first suggested in a perceptive editorial in the British 
Medical Journal in 1968. This proposed that there was a causal relationship 
between the administration of succinylcholine, altered metabolic rates in 
skeletal muscle tissues and the expression of the syndrome, thus focusing 
on the skeletal musculature as the site of the abnormality in human MH.
2Elevations in the resting levels of serum creatine phosphokinase (CPK) 
provided the first direct evidence associating MH susceptibility with an 
underlying myopathy (Denborough et al., 1970a; Isaacs and Barlow, 1970) 
and subsequent observations (Denborough et al. , 1970b) indicated that 
halothane anaesthesia markedly elevated CPK levels in an individual 
susceptible to MH.
Two myopathies have been described which predispose to MH (King et al., 
1972). The first occurs in young boys and is associated with obvious 
physical deformities (King and Denborough, 1973), while the second, and 
more common, is inherited as an autosomal dominant trait and the myopathy 
is usually subclinical (Denborough et al. , 1970a; Isaacs and Barlow, 1970).
The in vitro identification of contractile hypersensitivity to 
caffeine in human MH muscle (Kalow et al. , 1970) demonstrated an abnormality 
in the metabolism of calcium in affected muscle and established a useful 
diagnostic test with which to assess MH susceptibility. The failure to 
obtain abnormal contractures on exposure to halothane (Kalow et al. , 1970), 
contrasted with later reports which showed that halothane contractility 
was of diagnostic use in identifying MH susceptible muscle (Ellis et al. ,
1972; Moulds and Denborough, 1972). The unreliability of any single 
in vitro contracture test to accurately assess human susceptibility to MH 
prompted the evaluation of drug-induced contractures to a variety of 
agents, including halothane, caffeine, succinylcholine and potassium 
chloride (Moulds and Denborough, 1974a), and this approach provides 
unequivocal identification of affected individuals. The ability of MH 
muscle to give an increased contractile response to a variety of agents 
(Moulds and Denborough, 1974a)reinforces the view that affected muscle is 
characterised by an abnormality in the processes regulating calcium ion 
distribution. The exact site of the skeletal muscle abnormality in human
3MH is unknown.
The discovery of an experimental animal model (Hall et al. , 1966; 
Harrison et at., 1968) in the late 1960s provided a useful system for 
studying the biochemical basis of MH. The manifestations of porcine MH 
are similar to those described in human MH (Williams, 1976; Denborough,
1980) thus suggesting that the underlying mechanisms predisposing to MH 
are common to both. The in vivo effectiveness of the volatile anaesthetic 
halothane (Gronert and Theye, 1976a) and the muscle relaxant 
succinylcholine (Gronert and Theye, 1976b) in inducing MH in susceptible 
swine has centred investigations to elucidate its aetiology on the skeletal 
musculature (Campion and Topel, 1975). Elevations in the serum CPK levels 
in resting (Hall et al. , 1970) and post-halothane challenged swine (Woolf 
et al. , 1970) are consistent with observations made in susceptible humans 
(Isaacs and Barlow, 1970; Denborough et al. , 1970a, b) and further 
underline the similarities between human and porcine MH. The most 
conclusive evidence highlighting common underlying mechanisms predisposing 
to MH comes from the in vitro demonstration of drug-induced hypercontractility 
in isolated human (Moulds and Denborough 1974a) and porcine (Okumura et al. , 
1979) MH skeletal muscle. The similarity between the contractile 
responses to a variety of agents in the human (Moulds and Denborough, 1974a) 
and porcine (Okumura et al. , 1979) forms of the syndrome confirms the 
usefulness of the pig as an animal model for studying MH.
Biochemical studies in susceptible swine have shown that a number 
of chemical changes (Berman et al. , 1970) precede the development of both 
muscular rigidity and hyperpyrexia. These changes include rapid rises 
in oxygen consumption and carbon dioxide production, metabolic acidosis 
and gross changes in serum electrolyte levels (Berman et al., 1970).
4Biochemical information on the development and expression of the syndrome 
in susceptible humans is 'rather limited and the availability of an 
animal model, in which the syndrome can be readily induced, explains why 
so much more is known about porcine Mil than human MH. The syndrome has 
been reported in the Landrace, Yorkshire, Pietrain and Poland China breeds 
(Campion and Topel, 1975) although the rate of incidence varies considerably 
from breed to breed (Lucke et al. , 1979). The mode of inheritance of the 
syndrome in swine is complex and genetic mechanisms ranging from a single 
autosomal dominant gene with incomplete penetrance and/or variable 
expression (Woolf et al. , 1970) to two dominant genes acting in concert 
(Williams et al. , 1975) have been proposed. The confusion as to the exact 
mode of inheritance of porcine MH stems from the multiplicity of tests 
used to assess susceptibility (these include the"halothane test"(Eikelenboom 
et al. , 1974), the identification of blood types (Rasmusen et al. , 1976) 
and the in vitro assessment of skeletal muscle contractility to a variety 
of drugs (Okumura et al. , 1979) and from inherent biological variability, 
which results in a wide spectrum of MH sensitivity (Lucke et al. , 1979).
MH represents one of a number of stress related syndromes which 
have been described in certain breeds of swine; the others include the 
porcine stress syndrome (PSS) and the pale soft exudative (PSE) pork 
syndrome. It seems that MH, PSS and PSE may all be different manifestations 
of a common underlying abnormality (Nelson, 1973; Denborough, 1980) but 
such an abnormality remains to be identified. The in vivo assessment of 
stress susceptibility in swine is generally carried out by the "halothane 
test" (Eikelenboom et al. , 1974; Campion et al. , 1974, 1979) further 
emphasising the relationship between PSS and porcine MH (Williams et al., 
1975). PSE pork is a post mortem characteristic which is predisposed by 
abnormal skeletal muscle metabolism in affected swine. The relationship
5of the PSE pork syndrome to porcine MH has been demonstrated by the 
propensity of MH skeletal muscle to develop PSE characteristics post­
mortem (Nelson et al. , 1974). Breed distribution and a common underlying 
myopathy are common features of the 3 stress related syndromes in swine 
(Nelson, 1973) and expression of any of the syndromes may be induced by 
a multiplicity of common stressors including exercise, excitement, 
fighting, high environmental temperatures and the administration of certain 
drugs (Nelson et al. , 1974).
1.2 SUMMARY
Malignant hyperpyrexia is a dangerous complication of anaesthesia 
which occurs in individuals who have an underlying skeletal muscle disease. 
In humans two predisposing myopathies have been described, one is 
Tecessively inherited and associated with various physical abnormalities 
while the second is dominantly inherited and is usually subclinical.
Similar abnormal anaesthetic reactions have been described in swine, 
suggesting that the human and porcine forms of MH are related disorders. 
Porcine MH, PSS and PSE appear to be different manifestations of a common 
underlying skeletal muscle abnormality.
1.3 PROJECT AIMS
In order to more fully document functional and/or structural 
abnormalities which reflect MH susceptibility, a multidisciplinary approach 
will be adopted. A variety of chemical, biochemical and pharmacological 
techniques will be used to achieve this aim.
A detailed biochemical characterisation of muscle microsomal 
membranes will be carried out using normal and MH porcine skeletal muscle
6in an attempt to correlate the functional abnormality in MH with a 
membrane associated lipid or protein abnormality. H1, F19 and P31 
nuclear magnetic resonance (NMR) spectroscopy provide a non-perturbing 
technique with which to study structure-function relationships and these 
methods will be used to study membrane function in MH. Some aspects of 
halothane-membrane interactions will also be investigated in artificial 
lipid membranes with the aim of providing more detailed information on the 
nature of this interaction and how membrane organisation affects this 
relationship.
Pharmacological studies will include the in vitro assessment of 
drug-induced contracture as a function of temperature, and the effects of 
the calcium antagonist TMB-8 on drug-induced contractures in normal and 
MH porcine skeletal muscle.
The functional similarities with skeletal muscle that platelets 
display, and their ready availability has prompted a study of platelet 
function in MH individuals, with the aim of developing a simple reliable 
technique with which to assess MH susceptibility in humans. Aggregatory 
responses to a number of drugs will be assessed in some detail in normal 
and MH humans in whom susceptibility will be simultaneously assessed by 
muscle biopsy and subsequent pharmacological testing.
7CHAPTER 2
STRUCTURE AND FUNCTION OF NORMAL AND MALIGNANT 
HYPERPYREXIC SKELETAL MUSCLE
2.1 INTRODUCTION
In MH the evidence favouring skeletal muscle as the principle site 
of the abnormality is extensive (Campion and Topel, 1975; Britt, 1977,
1979; Lucke et at. , 1979; Denborough, 1980) and it is generally held
that initiation of the syndrome occurs as a consequent expression of 
a structural and/or functional lesion in this tissue in response to a 
specific trigger. The muscular rigidity and the elevations in the blood 
levels of the muscle associated CPK enzyme, which occur during the 
development of the syndrome (Chapter 1) provide supportive evidence for 
a skeletal muscle abnormality but it was the in vitro demonstration of 
drug-induced contractile hypersensitivity which provided the most conclusive 
evidence indicative of MH skeletal muscle dysfunction (Kalow et at. , 1970; 
Ellis et at., 1972; Moulds and Denborough, 1972). Prior to discussing 
the nature and extent of the proposed skeletal muscle lesions a description 
of the structure and function of skeletal muscle will be presented.
2.2 SKELETAL MUSCLE STRUCTURE AND FUNCTION
The organisational detail in skeletal muscle ongoing from 
macroscopic to microscopic structures is rather simply shown in 
Figures 1, 2 and 3. Intact muscle is composed of bundles of individual 
cells or fibres called fascicles. Each individual fibre and bundle is 
embedded in a connective tissue matrix called the endomysium and 
perimysium, respectively. The complete muscle is in turn sheathed in
8an additional connective tissue matrix termed the epimysium. The 
geometric specifications of the individual fibres may vary considerably 
but each fibre is intact along the whole length of the muscle'and 
individual fibres may be up to 30 cms in length. The fibres are 
physically anchored to tendons by the terminal sections of the fibre and 
the tendons are in turn attached to adjacent bones. Each cell is mono- 
nucleated with the nucleus located close to the plasma membrane. The 
plasma membrane or sarcolemma is a specialised membrane and is characterised 
by a limited region which is pharmacologically responsive to the chemical 
transmitter acetylcholine. This specific region, the motor end plate (MEP) 
represents the locus of interaction between nerve and muscle, and is the 
functional site for neuromuscular transmission. Sensitivity to 
acetylcholine differentiates the MEP from the remainder of the sarcolemma 
while the reverse is true for responses to directly applied electrical 
current as the MEP is electrically inexcitable (Bowman et at. , 1969) . 
Mammalian foetal skeletal muscle fibres are polyneurally innervated but 
this pattern disappears within a few months of birth,at which stage each 
fibre is connected to only one motoneurone (Vrbovä et al. , 1978).
In vivo, skeletal muscle contractility is controlled by the motoneurone, 
where neural stimulation induces the release of acetylcholine, which in 
turn mediates depolarisation of the MEP. The resting sarcolemma is 
electrically asymmetric, with the interior maintained approximately 90 
mvolts more negative than the outer surface. This potential difference 
is a consequence of the maintenance of steep energy dependent ionic 
gradients (i.e. high potassium and low sodium inside and the reciprocal 
outside). The receptor-mediated interaction between acetylcholine and 
the MEP depolarises the end plate and results in an increase in ionic 
permeability. This localised depolarisation means that the potentials in 
the end plate region and the remainder of the sarcolemma differ, and this
9constitutes the initial step in the translation and amplification of the 
neural impulse to the remainder of the sarcolemma. On reaching a critical 
value depolarisation becomes self perpetuating and it spreads radially 
from the MEP. Thus, initiation and propagation of the action potential 
occur rapidly and passes around the muscle fibre membrane within 
milliseconds. The MEP possesses an active acetylcholinesterase which 
rapidly hydrolyses the released acetylcholine and on repolarisation the 
MEP is ready to respond to a further release of acetylcholine.
The requirement for some process to facilitate the propagation of 
the action potential into the muscle fibre was postulated in 1948 (Hill, 
1948) and experimentally verified a number of years later (Huxley and 
Taylor, 1958). Utilising electrophysiological techniques Huxley and 
Taylor (1958) showed that the postulated process was in fact the 
invaginations of the T-tubules and that this is the pathway along which the 
action potential is conducted into the interior of the fibre. T-tubular 
continuity with the extracellular fluid, and the extent to which the 
system penetrates the muscle fibre, was demonstrated by Huxley (1964), 
who showed that ferritin (which under normal conditions does not cross 
cell membranes) could specifically localise within the T-tubular membrane 
system. Two functions are fulfilled by the T-tubular network. These 
are, (1) the propagation of the sarcolemma initiated action potential 
along the length of the tubule and (2) to communicate this activation 
signal to the sarcoplasmic reticulum (SR) through the specialised 
junctional regions where the two membrane systems interact (Costantin, 
1975). Little is known about the nature of the activation signal that is 
transmitted from the T-tubule to the terminal cisternal sections of the 
SR although a number of mechanisms have been postulated (Endo, 1977). 
Voltage controlled charge movement has been proposed to be the primary 
process modulating the release of calcium from the terminal cisternae and
10
at least two voltage controlled mechanisms are compatible with this 
scheme (Adrian, 1978). In the first a direct electrical coupling 
between the T-tubular and terminal cisternal membranes has been proposed, 
with the release of activator calcium being voltage regulated (Adrian,
1978). An alternative scheme suggests that the eventual release of 
activator calcium from the terminal cisternae is controlled by the prior 
release of T-tubular trigger calcium and that this initial release of 
trigger calcium is the voltage controlled event (Endo, 1977). The 
latter mechanism, more simply referred to as calcium-induced calcium 
release, has received indirect experimental support in skinned fibre 
preparations where high extracellular calcium causes appreciable release 
of bound SR calcium (Endo, 1977). Such results were obtained with 
unphysiologically high calcium levels and its importance in controlling 
normal skeletal muscle calcium release has been proposed to be minimal 
(Endo, 1977). The electron microscopic demonstration of "feet” 
apparently spanning the 12 nm gap between the T-tubular and terminal 
cisternal membranes (Franzini-Armstrong, 1975) provided a possible 
structure by which electrical continuity could be maintained. Indeed 
Schneider and Chandler (1973) have presented evidence correlating the 
number of these "feet" to their estimate of the number of moving charge 
groups per unit area of membrane.
Although evidence favouring the involvement of such "feet" in 
the coupling of T-tubular excitation to SR calcium release is circumstantial, 
(Schneider and Chandler, 1973), a number of observations are pertinent to 
this relationship; (1) the "feet" originate from the terminal cisternae 
(Franzini-Armstrong, 1975), (2) they occur only at the T-tubular-SR 
junctions (Franzini-Armstrong, 1975), (3) their number increases after 
a potassium chloride-induced contracture (Eisenberg et al. , 1979) and in
11
fatigued muscle (Eisenberg and Gilai, 1979) and (4) there is a 
correlation between their localised occurrence (Franzini-Armstrong,
1975) and the release of calcium, which is known to occur from the 
terminal cisternae (Winegrad, 1970). Despite the aforementioned 
relationships between the presence of the SR associated "feet" and the 
transmission of the contractile activation signal from the T-tubule to the 
terminal cisternae, the mechanisms underlying excitation-contraction (E-C) 
coupling largely remain unknown and this step represents the least 
characterised process in the skeletal muscle contraction-relaxation cycle.
Irrespective of the nature of the activation signal that is 
conveyed to the terminal cisternae, it is important to note that this 
signal does not initiate an all or none response and that the amount of 
SR calcium released is a function of the extent of T-tubular depolarisation 
(Costantin, 1975).
With the release of calcium from the terminal cisternae, fibre 
contractility is controlled by two opposing processes; (1) calcium 
re-uptake by the longitudinal SR, which results in relaxation and (2) the 
regulatory interaction of calcium with the troponin-C protein which is a 
prerequisite for the mechano-coupling of actin to myosin. Prior to 
elaborating on these processes it is first appropriate to outline the 
morphological features of the myofibrillar elements within the sarcomere 
and more importantly how their co-ordinated interaction results in the 
generation of muscle tension.
Electron microscopy of intact fibres and biochemical analysis of 
the individual myofibrillar protein constituents have collectively 
provided an almost complete picture of the functioning of the contractile 
apparatus. Each sarcomere stretches from adjacent Z lines and is 
composed of thick and thin filaments. These filaments overlap at certain
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stages giving the sarcomere a distinctly banded appearance. Thus the 
I, H, and A bands constitute thin filaments, thick filaments and a 
region where both overlap, respectively (Figures 1 and 2). The thin 
filaments consist of a double helix of tropomyosin along which 7 G-actin 
molecules are aligned per tropomyosin molecule. An additional protein, 
troponin, is also localised on the thin filaments and this constitutes a 
tri-subunit complex consisting of; (1) troponin-C, the calcium binding 
segment, (2) troponin-T, the segment responsible for the troponin- 
tropomyosin interaction and (3) troponin-I the inhibitory subunit which 
in resting muscle physically blocks the interaction of actin with myosin 
(Murray and Weber, 1974).
Electrophoretic analysis has shown that the thick filaments contain 
three proteins, but a specific function has been ascribed only to the 
predominant myosin protein. The specific interaction of myosin with an 
actin molecule in the thin filament is the process upon which muscular 
contraction is based.
The release of calcium from the terminal cisternae raises intra- 
cellular calcium levels from less than 10 M to greater than 5 x 10 M
and the affinity for calcium displayed by troponin-C is such that under 
these conditions 2 calcium ions are bound per subunit. This regulatory 
binding of calcium by troponin-C is somehow "felt” (Perry, 1979) by the 
adjacent troponin-I protein and the conformational change which results 
effectively frees the myosin binding site on the G-actin molecule. It is 
important to note that the interaction between the troponin-I protein and 
actin occurs only every seventh actin molecule and in the absence of a 
sufficiently high level of calcium, this interaction effectively blocks 
the myosin binding site on all actin molecules (Perry, 1979). Prior 
interaction of the myosin head group with ATP results in an energised
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intermediate which in the presence of calcium can interact specifically 
with act in. The myosin head then undergoes an energy consuming 
comformational change which alters the angular relationship of the 
cross bridge to the axis of the thin filament, thus resulting in the 
movement of the thin filament along the thick filament. In the presence 
of calcium and with a sufficient supply of ATP, actomyosin cross bridge 
formation takes place recurrently with a gradual decrease in the length 
of the H band. Tregear and Marston (1979) have outlined current ideas 
on the events associated with cross bridge formation and the description 
here represents a gross over-simplification of the kinetic events associated 
with actomyosin formation.
As long as the level of stimulation exceeds the contractile 
threshold for the muscle, tension is maintained. On the cessation of 
stimulation (either neural or drug induced) the surface membrane system 
is repolarised and the calcium concentrations return to resting levels 
as a consequence of the actively mediated uptake of calcium into the 
longitudinal sections of the SR. Calcium localisation during the 
contractile recovery phase occurs initially in the longitudinal sections 
of the SR but within seconds this calcium is transported to the terminal 
cisternal regions of the SR (Winegrad, 1970). Autoradiography has 
elegantly demonstrated this functional specialisation of discrete regions 
of the SR and has in addition shown that the release and re-uptake of 
calcium are continuous processes which occur in both resting and 
stimulated muscle (Winegrad, 1970). Thus in stimulated muscle the rate 
of calcium release greatly exceeds the re-uptake capacity of the muscle 
and contraction results. Figures 2 and 3 show how the different skeletal 
muscle membrane systems have developed to fulfil their specific roles in 
the contraction-relaxation cycle.
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Figure 2.1: Organisation of mammalian skeletal muscle
Schematic outline of the organisational detail in skeletal muscle 
on going from macroscopic to microscopic structures. (From Bloom 
and Fawcett, 1968).
Figure 2.2: Sarcomere organisation at the molecular level
This represents a schematic outline of myofibrillar and 
membrane organisation in individual sarcomeres. The sarcomere 
constitutes the regions between adjacent Z lines. (From 
Bloom and Fawcett, 1968).
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Figure 2.3: A three-dimensional reconstruction of mammalian
skeletal muscles
The spatial relationships of the individual membrane systems 
elegantly highlight the relationship of structure to function 
in skeletal muscle. The functional continuity between the 
sarcolemmal, T-tubular and SR membrane systems is essential for 
muscle function. (From Eisenberg et at., 1974).
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Over the last five years a great volume of work has appeared on 
the many aspects of muscle function, and extensive reviews have appeared 
on activation (Costantin, 1975; Podolsky, 1975; Adrian, 1978; Caputo,
1978) , calcium release (Endo, 1977), contractile protein functioning 
(Tregear and Marston, 1979; Mannherz and Goody, 1976; Tada et at, y 1978) 
and the energetics of muscle contraction (Curtin and Woledge, 1978;
Homsher and Kean, 1978). The previous section has drawn peripherally from 
these reviews and the presentation represents a simplistic outline of 
events which characterise the contraction-relaxation cycle in skeletal 
muscle fibres.
Thus having reviewed skeletal muscle structure as it relates to 
function, the next section examines the evidence favouring 
skeletal muscle abnormalities in MH.
2.3 SKELETAL MUSCLE ABNORMALITIES IN MALIGNANT HYPERPYREXIA
2.3.1 Muscular denervation and malignant hyperpyrexia
The enhanced contractility displayed by MH skeletal muscle in 
response to specific drugs (Moulds and Denborough, 1974; Okumura et at, ,
1979) suggests similarities with denervated muscle (Moulds, 1977, 1978) 
as contractile supersensitivity is a reported feature of such muscles in 
response to succinylcholine (Thesleff, 1974) and to caffeine (Gutman and 
Sandow, 1965). Experimentally denervated mammalian skeletal muscle has 
been extensively studied, and defined alterations characterise the chronic 
case (Vrbovä et at., 1978). Mononeural innervation (i.e. one MEP per 
muscle cell) is a feature of normal mammalian skeletal muscle but 
denervation alters this distribution and multiple extra-junctional 
cholinergic receptors explain the supersensitivity displayed by such 
muscle to cholinergic drugs (Fambrough, 1970). Systemic and regional
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administration of succinylcholine to humans with traumatic nerve injury, 
resulted in contractures in the denervated musculature and regional 
administration of fractional systemic doses has been proposed to be of 
diagnostic use in MH (Baraka,1978). In vitro skeletal muscle fibres from 
MH susceptible swine contracted spontaneously upon the addition of 
succinylcholine (Okumura et al. , 1979), but acetylcholine at similar 
concentrations failed to contract MH muscle (Okumura et at. , 1980).
This differential response to apparently related cholinergic drugs 
indicates that succinylcholine-induced contractures in MH muscle are not 
mediated by a cholinergic mechanism and that the extra junctional spread 
of cholinergic receptors does not occur in MH muscle.
Similar conclusions have been reached by Moulds (1977} 1978), who
found that denervated mouse muscle behaved quite differently to MH human 
muscle when assessed by a variety of parameters. Denervated muscle 
displayed a prolongation of the "active state" in response to electrical 
stimulation, a failure to contract when treated with 3% halothane and a 
contracture induced by succinylcholine blocked any subsequent response to 
either potassium chloride or to electrical stimulation (Moulds, 1977, 1978). 
MH muscle by contrast displayed no change in "active state", a large 
contracture in response to 3% halothane, and a non-depolarising 
succinylcholine contracture, as evidenced by the maintenance of twitch 
and the ability to subsequently contract to potassium chloride (Moulds,
1977, 1978). The collective results of Moulds (1977, 1978) and Okumura 
et al. (1980) exclude denervation as the primary skeletal muscle abnormality 
predisposing individuals to MH, although certain similarities do exist.
2.3.2 Sarcolemmal lesions in malignant hyperpyrexia
Excluding the specialised region at the end plate, the primary
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function of the sarcolemma is to amplify the radial spread of the 
activation signal initially generated at the neuromuscular junction.
The sarcolemma and T-tubular network are collectively responsible for the 
maintenance of the steep ionic gradients which are functionally expressed 
as the differential electrical potentials at either side of the surface 
membrane system. Alterations in resting membrane potential (RMP) in 
porcine MH skeletal muscle on exposure to halothane have been noted in 
forelimb digital extensor (Gallant et al. , 1979) and intercostal (G. Galloway, 
J. Bomstein, J. Sullivan and M.A. Denborough, unpublished results) 
muscles. An earlier study (Bradley et al. , 1973), also utilising inter­
costal muscle failed to observe any change in RMP on exposure to 
halothane, but these experiments may have been carried out at room 
temperature, where halothane contractures (Nelson et at. , 1975) and the 
halothane-induced partial depolarisation do not occur (G. Galloway, J. 
Bornstein, J. Sullivan and M.A, Denborough, unpublished results).
Indeed the failure by Bradley et al. (1973) to obtain an in vitro -halothane 
contracture would tend to support this possibility. Halothane-induced 
depolarisation did not occur in normal muscle preparations thus indicating 
that the partial depolarisation (average 5.1 mV, G. Galloway, J. Bornstein, 
J. Sullivan and M.A. Denborough, unpublished results) is a real phenomenon 
and is indicative of an underlying surface membrane lesion.
Kendig and Bunker (1972) have shown that under halothane 
anaesthesia the in vivo RMP of rat gostrocnemius muscle was depressed by 
an average of 6 mV compared to RMP recorded 3 hours after the cessation 
of anaesthesia in the equivalent spinalised animal. This may reflect a 
normal in vivo response to prolonged halothane anaesthesia (i.e. > 3  hours 
(Kendig and Bunker, 1972)) as normal pig, frog and mouse muscle RMP was 
not altered by thirty minutes in vitro exposure to halothane (Gallant et al. ,
20
1979). Thus it is possible that the partial depolarisation of porcine MH 
muscle obtained on in vitro exposure to halothane may be indicative of a 
much greater in vivo depolarisation. In isolation this depolarisation 
does not explain the enhanced contractility displayed by porcine MH 
muscle on in vitro exposure to halothane (Okumura et al. , 1979), but the 
lower mechanical threshold of porcine MH muscle (Bryant and Anderson,
1977) provides the necessary link correlating depolarisation to contraction. 
This shift in mechanical threshold activation effectively brings the 
electrical threshold quite close to the RMP (Bryant and Anderson, 1977) 
and hence the small halothane induced depolarisation may be sufficient to 
induce a contracture. The electrophysiological evidence favouring a 
surface membrane lesion in MH is good (reviewed above) but comparable 
studies on the structural composition of MH surface membranes have yet to 
be attempted and hence no attempt can be made to correlate such functional 
changes with defined structural abnormalities. The demonstration that 
this surface membrane lesion occurs in a white (Gallant, 1979; Gallant 
et al. , 1979) and a red (G. Galloway, J. Bornstein, J. Sullivan and M.A. 
Denborough, unpublished results) muscle is important as it indicates that 
this abnormality occurs independently of muscle fibre type.
2.3.3 Triad abnormalities in malignant hyperpyrexia
Glycerol-induced destruction of the T-tubule or replacement of the 
normal Ringer buffer with deuterium oxide-Ringer (020-Ringer) abolished 
twitch and blocked the hypersensitive contractures of porcine MH skeletal 
muscle in response to a number of drugs (Okumura et al., 1980). E-C 
coupling has been shown to be inhibited in the presence of D20 (Sandow 
et al. , 1976) or by pretreatment with glycerol (Dulhunty and Gage, 1973) 
and the inhibitory effects of such treatments on drug-induced contractures 
in MH muscle indicate that E-C coupling is abnormal (Okumura et al. , 1980).
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The extent of T-tubular destruction induced by glycerination is generally 
incomplete (Fatkin et al. , 1979) and the actual site of uncoupling is 
unknown. In MH muscle the return of hypersensitive drug contractures on 
returning to normal Ringer indicates that the uncoupling of the E-C 
process in the presence of D20 is completely reversible (Okumura et at. , 
1980). The triad is the functional site at which E-C coupling occurs and 
electron microscopy has shown (Franzini-Armstrong, 1975) that the portions 
of the T-tubular and terminal cisternae which constitute the triad are 
distinct from the bulk of these membrane systems. Structural asymmetry is 
a characteristic feature of the triad (Franzini-Armstrong, 1975) with 
junctional "feet" being localised specifically on the terminal cisternae. 
These "feet" constitute a direct physical link between the junctional 
membranes, and an increase in their number appears to accompany muscle 
activation (Eisenberg et al. , 1979). Such structures have been proposed 
to be involved in specific step(s) coupling excitation to eventual calcium 
release in frog skeletal muscle (Eisenberg et al. , 1979) and the rate of 
formation and/or destruction of these "feet" may be abnormal in MH 
skeletal muscle. Stereological analysis of the dystrophic chicken 
pectoralis muscle has shown an increase in surface and volume densities 
of the T-tubular system compared to the normal chicken muscle and this 
increase has been proposed (Crowe and Baskin, 1979) to partially account 
for the altered contractile properties characteristic of this form of 
dystrophy. Although no published evidence exists supporting either 
abnormal triad "feet" formation or alterations in the surface area of the 
T-system, both are consistent with the hyperexcitability that is an 
in vitro feature of MH skeletal muscle.
2.3.4 Sarcoplasmic reticular abnormalities in malignant hyperpyrexia
Specialisation of the SR has resulted in specific regions fulfilling
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quite distinct functions (Winegrad, 1970). Thus the terminal cisternae 
modulate calcium release while the longitudinal SR is responsible for 
calcium uptake. In the previous section the role of the terminal 
cisternae has been briefly considered as an integral functional unit of 
the triad and in this section the biochemical evidence favouring 
abnormalities in the ability of SR from porcine and human MH muscle to 
metabolise calcium is discussed. Britt and co-workers have found that 
calcium accumulation by SR from MU human muscle was less than normal 
(Britt et at., 1973a) while the equivalent process in MH swine SR was 
greater than normal (Britt et at. , 1975), and the extent of these differences 
increased in the presence of halothane. The greater than normal basal 
uptake of calcium by MH swine SR (Britt et at. , 1975) contrasts with the 
decreased calcium uptake and reduced calcium binding found in more recent 
studies (Nelson, 1978; Gronert et at., 1979). The in vivo assessment 
of the isometric twitch displayed by the tibialis anterior muscle of 
stress susceptible swine showed that the contracture time and the twitch 
tension were greater and the half relaxation longer than in the equivalent 
muscle of stress resistant swine (Campion et at., 1974, 1979). This 
indicates that in PSS skeletal muscle there is a lesion in the processes 
modulating calcium release and/or re-uptake. Campion and Topel (1975), 
Campion et at. (1976), Britt (1977, 1979) and Gronert et at. (1979) have 
extensively reviewed the experimental evidence favouring an SR abnormality 
in porcine MH, and it is generally believed that such an abnormality does 
exist but that its pathological contribution is unable to fully explain 
MH susceptibility in either the human or porcine forms of the syndrome.
2.3.5 Mitochondrial abnormalities in malignant hyperpyrexia
Mitochondrial metabolism is primarily concerned with the aerobic 
dependent generation of ATP. As a consequence, the metabolic competence
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of this organelle is under tight regulatory control. At very low adenosine 
diphosphate (ADP) levels a resting or state 4 respiratory rate prevails 
but upon the addition of ADP, active or state 3 respiration results, with 
an associated increase in oxygen uptake. The respiratory rate in the 
presence (state 3) or absence (state 4) of ADP, gives the respiratory 
control index (RCI) or more correctly the acceptor control index (ACI) 
which in intact, freshly prepared mitochondria may be 10 or more 
(Gronert and Heffron, 1979). Molar ADP utilisation per mole of oxygen, 
the ADP/0 ratio, together with the ACI gives two simple techniques with 
which to assess mitochondrial respiratory competence in vitro.
Early results obtained using swine (Denborough et al. , 1973b; 
Mitchelson, 1974) and human (Britt et al. , 1973b) muscle mitochondria 
showed that mitochondrial functioning was similar in normal and MH 
preparations both in the presence and absence of halothane. Mitochondria 
isolated from PSS muscle displayed similar state 3, state 4, ACI and 
ADP/0 ratios to normal muscle mitochondria (Campion et al. , 1975, 1976) 
and it is unlikely that a mitochondrial abnormality is a primary 
determinant of PSS susceptibility. Gronert and Heffron (1979) have shown 
that state 3 respiration and the rate of calcium binding in porcine MH 
mitochondria are approximately half those of normal porcine mitochondria 
and the authors have proposed that in MH,mitochondria are less "tightly 
coupled". This depression in the basal mitochondrial respiratory rate is 
indicative of an underlying myopathy (Gronert and Heffron, 1979) but in 
isolation this lesion could not account for the metabolic disturbance that
characterises an episode of MH. Decreased mitochondrial calcium binding 
in porcine MH (Gronert and Heffron, 1979) is consistent with the increased 
mitochondrial calcium efflux rates reported by Cheah and Cheah (1978, 1979).
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If the in vitro preference for calcium uptake at the expense of 
oxidative phosphorylation (Carafoli, 1975) is also a mitochondrial feature 
in vivo then the raised myoplasmic calcium levels that are maintained 
during MH would result in mitochondrial calcium uptake with eventual 
uncoupling of oxidative phosphorylation. The energy dependent uptake of 
calcium together with the decreased calcium binding capacity, increased 
calcium efflux rates and uncoupling of oxidative phosphorylation would 
quickly deplete ATP levels and eventually lead to cell necrosis. This 
"vicious cycle" of mitochondrial calcium overload and ATP depletion has 
been proposed to be a common terminal event in a wide variety of muscle 
disorders (Wrogemann and Pena, 1976).
2.3.6 Contractile protein abnormalities in malignant hyperpyrexia
The regulation of contractile activity distal to calcium release 
is complex with primary control being exerted by the interaction of calcium 
with the thin filament localised troponin complex (Murray and Weber, 1974; 
Perry, 1979). Alterations in intracellular pH which accompany MH (Bennet 
et at. , 1978) complicate any attempts to correlate altered contractile 
protein functioning with an underlying abnormality.
Tension development in glycerinated porcine fibres is pH dependent 
(Izumi et at. , 1977) and the lower pH values which characterise PSE 
muscle ensure that rigor occurs more readily as a consequence of 
irreversible actomyosin cross bridge formation. Specific differences in 
the thick filament protein myosin have been reported (Park et at., 1975), 
but these probably reflect altered activities rather than a specific 
difference in myofibrillar protein composition (Kany et at., 1978), and 
this altered functioning is most likely a result of the lower pH in PSE
muscle.
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2.3.7 Energy metabolism and malignant hyperpyrexia
Muscle energy consumption is unevenly divided in the contraction- 
relaxation cycle with 2/3 utilised during the active contractile phase 
(Lehninger, 1975). Thus energetic insufficiency would have quite dramatic 
effects on the skeletal muscle contraction and relaxation.
The role of CPK in muscle energetics is crucial, as its presence 
and normal functioning are essential in maintaining energetic sufficiency 
within the cell. Elevations in serum CPK levels may characterise a number 
of muscle disorders, but such an elevation should not be regarded as 
indicative of any single muscle disorder. Such diverse factors as age, 
sex, race, level of fitness, neurological condition, drug ingestion and 
trauma have been shown to effect serum CPK levels (Zsigmond, 1978). The 
elevated serum CPK levels often encountered in NO! individuals are most 
likely indicative of a "fragile" sarcolemma (Britt, 1977), and it is 
possible that a substantial loss of CPK from muscle may affect the energetic 
competence of the cell (Pennington, 1978). In the absence of halothane 
both MH human (Isaacs et al. , 1975) and swine (Van den Hende et al. , 1976) 
muscle possess lower amounts of creatine phosphate (CP) than normal muscle, 
and when challenged with halothane MH muscle is rapidly depleted of CP and 
ATP (Harrison et at, , 1969; Nelson et at,, 1972; Bremen and Kench, 1973; 
Britt et at., 1977; Van den Hende et al., 1976) while such decreases are 
small in normal muscle. The rapid depletion in the energetic "currency" of 
the cell would have dramatic effects on contraction, where irreversible 
actomyosin cross-linking occurs (Britt, 1977, 1979), and on relaxation 
where myoplasmic calcium levels remain above the contractile threshold as 
a direct consequence of the critically low intracellular CP and ATP 
concentrations. This decrease in ATP levels may be due to a primary lesion 
in the functioning of one or more of the enzymes associated with ATP
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regeneration or as a secondary response to the altered intracellular pH 
and raised calcium levels. The former possibility has been proposed by 
Schmidt et al. (1974) and deficiencies in the activity of adenylate kinase 
(AK) in human MH muscle have been documented (Schmidt et al. , 1974;
Schmidt and Heller, 1977). The latter enzyme catalyses the reaction,
2 ADP ^ AMP + ATP
and in energetically active tissues (e.g. muscle) it plays an important 
role in maintaining the energy charge (Atkinson, 1968) of the cell.
Partial (^70% activity, K. Schmidt, personal communication) and almost 
complete (<20% activity, Schmidt et al. , 1974) AK deficiencies have been 
described. Two individuals in the latter category failed to survive 
halothane anaesthesia while an individual with a partial AK deficiency 
survived an episode of MH. Halothane binds specifically in the adenine 
niche of AK (Sachsenheimer et al. , 1977) and as such may be considered 
an unusual, reversible inhibitor of AK. The decreased presence and/or 
activity of AK (Schmidt et al. , 1974) together with the specific AK- 
halothane interaction (Sachsenheimer et al. , 1977) may result in a 
breakdown in the cellular processes mediating ATP regeneration during MH 
and death may or may not occur depending on the extent of the AK deficiency 
(K. Schmidt, personal communication).
Futile cycling (Williams, 1976) and an enhanced glycolytic rate 
(Bremen and Kench, 1973) are time dependent features observed in MH swine 
under halothane anaesthesia and represent additional breakdown points in 
cellular energy metabolism.
2.3.8 Cyclic nucleotides and malignant hyperpyrexia
Since an enhanced glycolytic rate is an apparently common feature 
of PSS, PSE, MH skeletal muscle, a number of studies (Ono et al. , 1976a, b,
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1977a, b) have attempted to correlate the known stimulatory effects of 
cyclic AMP (cAMP) on glycogenolysis (Britt et at. , 1977, 1979) with stress 
susceptibility. Although cAMP levels were significantly higher at three 
minutes post mortem in stress susceptible swine (Ono et at. , 1976a, 1977a) 
no differences were detected in the activities of adenylate cyclase or 
phosphodiesterase (Ono et at. , 1977b) in normal and stress susceptible 
porcine skeletal muscle. Abnormalities in the metabolism of cAMP have 
been reported in human dystrophic muscle (Mawatari et at., 1974; Canal 
et at. , 1977) but the consequences of such abnormalities are far from 
understood. The recently demonstrated association between cAMP and calcium 
release (Raible et at. , 1978) and cyclic GMP (cGMP) and decreased 
glycogenolysis (Beitner et at. , 1978) in skeletal muscle provide important 
sites of action for the cyclic nucleotides but the relevance of such 
associations to MH muscle is unknown.
2.3.9 Histochemical and morphological abnormalities in malignant 
hyperpyrexia
The extent and type of innervation determines many of the 
functional properties of mammalian skeletal muscle (Vrbovä et at. , 1978) 
and many such different properties have been exploited in the development 
of histochemical techniques to identify different fibre types.
Classificatory schemes are numerous (Addis, 1978) and most are based on 
the relative presence of a number of key metabolic enzymes. The most 
widely used categorises fibres as one of thi*ee types:
Type 1; low ATPase, high succinate dehydrogenase, oxidative, slow 
twitch, red fibres.
Type 2a; intermediate ATPase and succinate dehydrogenase, oxidative- 
glycolytic, fast twitch, pale fibres.
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Type 2b; high ATPase, low succinate dehydrogenase, glycolytic, fast 
twitch, white fibres.
Thus histochemical designation is indicative of a more subtle biochemical 
association, with myoglobin content, glycolytic rate, mitochondrial 
content, the extent of development of the SR, SR calcium uptake capacities 
and the muscle relaxation rate (Beecher et al. , 1965; Fiehn and Peter,
1971; Eisenberg and Kuda, 1975) all being related to muscle fibre type. 
Therefore, the accurate classification of muscle fibre types is essential 
in the detailed assessment of muscle function in any muscle disorder as 
simple alterations in muscle fibre type may result in dramatic changes in 
associated contractile properties (Close, 1972; Vrbovä et at., 1978), 
Morphological and histochemical examination provide simple and rapid means 
with which to assess muscle damage and their application in studies related 
to MH has been widely exploited (Isaacs, 1978; Palmer et al. , 1978;
K. Hopkinson and M.A. Denborough, unpublished results). In MH human muscle 
pathological findings have been variable, but their occurrence supports 
the contention that an underlying myopathy exists in at least some 
susceptible individuals. These changes have included an increase in type 1 
fibres, fibre type grouping, peripheral fibre atrophy, variable fibre 
size, the presence of central cores, altered localisation of nuclei, 
ruptured mitochondria, and distended SR (Denborough et al. , 1973a; Isaacs 
et al. , 1973; Gullotta and Helpap, 1975; Isaacs and Heffron, 1975;
Harriman et al. , 1978; Hull et al. , 1978; Isaacs, 1978; Riske-Nielson,
1978; K. Hopkinson and M.A. Denborough, unpublished results).
In porcine muscle the most common pathological finding relates to 
the increased presence of giant myofibres in the musculature of stress 
susceptible swine (Dutson et al. , 1978). supercontracted fibres appear 
more frequently in MH swine muscle than in comparable normal muscle (Venable,
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1973; Palmer et dl. , 1978) and it is possible that there is a correlation 
between the occurrence of giant myofibres and supercontraction (Dutson 
et al. , 1978). The pathological features that are common in human MH 
skeletal muscle are less frequent in MH porcine muscle (Palmer et al. , 1978).
2.3.10 Dantrolene sodium, skeletal muscle and malignant hyperpyrexia
The ability of dantrolene to preferentially act on skeletal rather 
than on smooth or cardiac muscle or other non-muscle tissues, prompted its 
initial use in the treatment of MH (Harrison, 1975) and its successful use 
in vivo (Harrison, 1975; Gronert et al. , 1976c; Jardon et al. , 1976; 
Harrison, 1977; Kerr et al. , 1978) together with its known tissue site 
of action are consistent with the primary MH lesion being skeletal muscle 
localised. Its in vitro effectiveness in preventing or reversing abnormal 
drug contractures (Anderson et al. , 1976, 1978; Austin and Denborough,
1977; Okumura et al. , 1980) provides definitive support for the 
extent and importance of skeletal muscle lesions in MH. Experiments on 
skeletal muscles from a number of vertebrate and invertebrate sources has 
shown that dantrolene, at low doses, has little effect on the electrical 
properties of the surface membrane (Ellis and Bryant, 1972), the neuro­
muscular junction (Ellis and Carpenter, 1972), SR calcium uptake (Yamamota 
et al. , 1977) or SR ATPase activities (Green et al. , 1976; Yamamoto et al. ,
1977) and its primary effect is exerted via antagonism of intracellular 
calcium release (Ellis and Carptenter, 1972; Van Winkle, 1976; Francis,
1978) . Intact fibre experiments utilising the calcium sensitive 
photoprotein aequorin (Desmedt and Hainaut, 1979; Lopez et al. , 1979) have 
confirmed the specific antagonism by dantrolene of calcium release.
Although the detailed molecular site of action of dantrolene is as yet 
unclear a number of processes have been considered, including the antagonism
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of a natural ionophore (Morgan and Bryant, 1977; Allay et at., 1978), 
inhibition of T-tubular or trigger calcium release (Putney and Bianchi, 
1974; Takauji et at., 1975; Miglietta, 1977; Nelson and Denborough, 
1977; Takauji et at., 1977; Oba and Hotta, 1978), SR calcium release 
(Van Winkle, 1976; Francis 1978) and other as yet not fully characterised 
functional sites within the triad (Suzuki and Hotta, 1976; Yagi and Endo, 
1976; Takauji and Nagai, 1977; Yamamoto et at., 1977).
2.4 SUMMARY
In MH,a wide body of evidence favours skeletal muscle as the 
crucially affected site, and the dysfunction induced in this tissue 
on exposure to an appropriate trigger is directly related to the high 
mortality rate characteristic of the syndrome.
Specific abnormalities have been described in a number of muscle 
processes including sarcolemmal depolarisation, electrical threshold 
activation, excitation-contraction coupling, sarcoplasmic reticular and 
mitochondrial calcium metabolism, ATP regeneration and drug-induced 
contraction. An attempt has been made to correlate the descriptive 
approach of normal muscle structure and function with the experimental 
observations on specific abnormalities reportedly found in MH skeletal 
muscle.
A more precise identification of the skeletal muscle lesion(s) 
and of their relative importance in the expression of the syndrome has been 
afforded with successful therapeutic and experimental utilisation of the 
thiohydantoin drug dantrolene sodium. This latter drug completely abolishes 
the drug-induced hypercontractility that is an in vitro feature of isolated 
MH muscle and in addition offers in vivo protection against the initiation 
of MH in susceptible swine.
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CHAPTER 3
ISOLATION AND CHEMICAL CHARACTERISATION OF NORMAL AND 
MALIGNANT HYPERPYREXIC PORCINE SKELETAL MUSCLE MICROSOMES
3.1 INTRODUCTION
3.1.1 Muscle membrane abnormalities in malignant hyperpyrexia
The evidence favouring skeletal muscle as the primary affected 
tissue in MH has been presented in Chapters 1 and 2. Despite the widely 
held view that the skeletal muscle abnormality in MH is membrane localised 
(Britt, 1977, 1979; Denborough, 1980), no systematic studies have been 
undertaken to characterise the chemical composition of muscle membranes 
in either porcine or human MH skeletal muscle. Such an approach has 
documented alterations in the lipid (Takagi et at., 1973; Rubsmen et at., 
1976; De Kretser and Livett, 1977; Swift et at., 1979) and protein 
(Scales et at. , 1977) composition of muscle microsomes in a number of 
forms of dystrophy.
There is limited evidence favouring the notion that in MH, muscle 
membranes are characterised by a structural abnormality (McIntosh and 
Berman, 1974; Cheah and Cheah, 1978). Whole muscle homogenates and 
subcellular fractions from PSE susceptible porcine skeletal muscles are 
characterised by a higher degree of fatty acid unsaturation in membrane 
phospholipids, and such changes have been proposed to explain the altered 
permeability characteristics that are a feature of this myopathic condition 
(McIntosh and Berman, 1974). Arrhenius plots of calcium-stimulated 
mitochondrial respiration show that MH mitochondria display higher 
transition temperatures than those of normal preparations and this 
difference has been proposed to reflect a more saturated fatty acid profile
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in phospholipids of MH muscle mitochondria (Cheah and Cheah, 1978). 
Therefore the reports which have relevance to this topic have produced 
conflicting evidence as to the nature and extent of this abnormality, 
as both an increase (Cheah and Cheah,1978) and a decrease (McIntosh and 
Berman, 1974) in the saturated/unsaturated fatty acid ratio of muscle 
membrane phospholipids have been proposed to be the underlying structural 
abnormality predisposing to MH.
The procedures utilised in isolating membrane fractions are of 
importance in any study designed to chemically characterise the isolated 
product and the fractionation scheme used and the rationale behind its 
use is presented in the following section.
3.1.2 Fractionation of skeletal muscle membranes
The isolation of pure subcellular muscle fractions was not a 
prerequisite in this study. The major requirements were for a mild and 
reproducible fractionation procedure based on established methods which 
would permit a comparative study of microsomal membrane composition between 
normal and MH skeletal muscles. A survey of the literature related to 
skeletal muscle membrane fractionation procedures revealed that a wide 
variety of methods were available which isolated membrane material of 
varying degrees of purity. A common feature in most of these isolation 
schemes has been the use of sucrose denisty gradient centrifugation, which 
utilises buoyant denisty as the deciding parameter in the isolation of 
membrane material.
The application of density gradient centrifugation to skeletal 
muscle membrane separation was first attempted in the mid 1960s (Hasselbach 
and Makinose, 1963; Konoshita et at. , 1964; Searydarian and Mommaerts, 
1965) and its early success in isolating discrete muscle subfractions has
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ensured its continued use. Sucrose density gradient centrifugation in 
combination with high ionic strength buffers (to minimise contamination 
with contractile proteins) has been widely used to isolate surface (Boegman 
et al., 1970; Festoff and Engel, 1974; Schapira et al. , 1974; Agapito and 
Cabezas, 1977; Smith and Appel, 1977; Bermego et al. , 1978; Reddy et al. , 
1978; Biarchi et al. , 1979) and intracellular (Martonosi and Halpin, 1971; 
Meissner, 1975; McIntosh et al. , 1977) membranes from skeletal muscle. 
Recent evidence suggests that morphological alterations and a loss of 
peripherally associated membrane proteins occur when high ionic strength 
buffers are included in isolation procedures (Lau et al. , 1977; Campbell 
et al. , 1979). A number of other reports have appeared where the use of 
high ionic strength buffers has been avoided and the isolation of a variety 
of subcellular fractions has been achieved with minimal contractile protein 
contamination (Kidawi et al. , 1973; Kidawi, 1974; Caswell et al. , 1976; 
Lau et al. , 1977; Biarchi et al. , 1977, 1979). These latter isolation 
methods were compatible with the requirements initially set out (i.e. mild 
and reproducible) and the isolation scheme utilised here represents a 
modification of these methods.
This chapter outlines the isolation procedure employed in the 
fractionation of microsomal membranes from normal and MH porcine skeletal 
muscle. Low ionic strength solutions in combination with discontinuous 
sucrose density gradient centrifugation have been used to fractionate 
muscle microsomes on the basis of buoyant density. The chemical 
composition of these microsomal fractions has been characterised with 
respect to protein and lipid content in an attempt to detect compositional 
differences which may reflect susceptibility to MH.
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3.2 MATERIALS AND METHODS
3.2.1 Animals and methods of anaesthesia
The animals in these studies were bred at the John Curtin School 
of Medical Research experimental farm at Braidwood, New South Wales.
These animals were produced from crosses of MH susceptible Landrace and 
Large White breeds. Normal animals were obtained from the same source.
In all cases MH susceptibility was assessed by recognised pharmacological 
criteria (Okumura et at. , 1979).
Similar procedures were utilised for the collection of muscle 
from normal and MH swine. Animals were premedicated with the neuroleptic 
Azaperone (4’-f luoro-4-(4-(2-pyridyl)-l-piperazinyl)butyrophenone) 4 mg/ml 
intramuscularly and thiopentone was administered by an ear vein cannula. 
Tracheal intubation was carried out after anaesthesia was induced with 
3-5 mg/kg of thiopentone. Anaesthesia was maintained with nitrous oxide 
in oxygen and supplemented with thiopentone when required. Segments 
(50-100 grams) of the trapezius and longissimus dorsi (1. dorsi) muscles 
were removed from the animal and immediately frozen in liquid nitrogen.
The section of 1. dorsi muscle used in this study was excised ventral from 
the first lumbar vertebra. Animals were then dispatched with a bolt gun 
and rapidly exsanguinated. In all experiments muscle was removed under 
anaesthesia and post mortem collection of muscle was not employed.
3.2.2 Halothane anaesthesia
In a number of normal (2) and MH (6) swine, additional muscle 
was removed after halothane (1-2%) anaesthesia. After collecting muscle 
from one side under nitrous oxide-barbiturate anaesthesia, animals were 
maintained for an additional hour under halothane and segments of trapezius 
and 1. dorsi muscle were then removed from the opposite side. These animals
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were then shot and exsanguinated.
Nitrous oxide-barbiturate anaesthesia was uneventful in all the 
normal and MH swine. Mild hypothermia was the only noticeable feature 
of halothane anaesthesia in the two normal swine. The clinical features 
of MH (Chapter 1) although slow to develop were present in four of the 
six MH swine after 1 hour of halothane anaesthesia. In the two remaining 
MH swine halothane anaesthesia was uneventful and susceptibility was 
confirmed by the development of the syndrome in response to i.v. succinyl 
choline (2 mg/kg).
3.2.3 Muscle fractionation
Muscle was maintained at -60°C and fractionation was initiated 
within 24 hours of removal. Frozen muscle was partially thawed, fat and 
connective tissue removed and then finely diced. The diced muscle was 
then homogenised in 3 volumes of 8% (w/v) sucrose in a Waring blender 
for 1 minute (40 seconds low speed, 20 seconds high speed). The blades of 
the blender were reversed to minimise organelle damage (Roesenthal et al. , 
1965) and to decrease extraction of contractile proteins. The fractionation 
scheme is shown in Figure 3.1. The homogenate was filtered through 20 
layers of cheese cloth and the residue discarded. The filtrate was 
centrifuged at 59,000 g for 45 minutes utilising a Beckman 30 rotor and 
a Beckman L-35 ultracentrifuge. The pellets were resuspended in 8% (w/v) 
sucrose and layered (10 ml/tube) on a discontinuous sucrose gradient 
consisting of 15 ml of 45% (w/v) sucrose and 12 ml of 30% (w/v) sucrose. 
Cellulose nitrate tubes (3^ by 1 inch) were used and centrifugation was 
carried out in a Beckman SW 27 swing out rotor at 96,000 g for two hours.
The suspensions recovered from the 8-30% and 30-45% interfaces were 
pelleted at 59,000 g for 45 minutes in the 30 rotor. The membrane samples
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were resuspended in 10 ml of distilled water and aliquots assayed for 
protein content. Samples of known protein concentration were removed 
for chemical and physical analysis and stored at -60°C until required.
3.2.4 Binding of tritiated ouabain
A total of four (2 normal, 2 MH) swine were used in these 
experiments and only the 1. dorsi muscle was used. Tritiated ouabain 
(20 yCi (approximately 20 pmoles), The Radiochemical Centre) was 
dissolved in 10 ml of a modified Ringer buffer (121 mM NaCl, 5.4 mM KC1, 
1.2 mM MgSOy, 1.2 mM Nal^POy, 15 mM NaHC03, 11.5 mM d-glucose and 2.5 mM 
CaCl2)• Under nitrous oxide-barbiturate anaesthesia the 1. dorsi muscle 
was exposed and the ouabain solution was injected directly into the muscle 
at several points. Anaesthesia was continued for a further 20 minutes and 
the injected segment of the muscle was removed prior to dispatching the 
animal with a bolt gun. Microsomal fractionation was initiated within one 
hour of excision and the fate of the label was followed by liquid 
scintillation spectroscopy. Aliquots (200 yl) were removed throughout 
the fractionation procedure, added to 10 ml of an aqueous based liquid 
scintillant mixture (66% xylene (v/v), 33% triton x-100 and 0.5% (w/v)
2,5-diphenyloxazole)and counted in a Packard Tri-Carb Liquid Scintillation 
Spectrometer.
The ouabain concentration was calculated by counting an aliquot 
of the tritiated ouabain solution and using a value of 49 Ci/mmol for 
the specific activity (Radiochemical batch analysis, The Radiochemical 
Centre). Ouabain binding was expressed as pmoles bound per individual
fraction.
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3.2.5 Electron microscopy
Pelleted fractions were fixed in 5% glutaraldehyde in 0.1 M sodium 
cacodylate, pH 7.4 and post fixed in 1% osmium tetroxide. Graded 
dehydration was achieved through a series of acetone washes (30% up to 
100% (v/v)) and the samples were then embedded in Spurs resin. Sections 
were cut with a diamond knife (Dupont) on a Reichart 0MU2 ultramicrotome 
and post stained in saturated solutions of uranyl acetate (45 minutes) 
and "Reynolds” lead citrate (20 minutes).
The sections were observed in a Phillips 300 Electron Microscope.
3.2.6 Protein estimation and amino acid analysis
Protein content in fractions was estimated as described by Lowry 
et at. (1951) with a two point double log plot used to construct a 
standard curve (Peterson, 1977). Amino acid analysis was performed by 
Mr L.B. James, Department of Biochemistry, John Curtin School of Medical 
Research, Canberra, by the method of Moore et at. (1958).
3.2.7 Protein electrophoresis
Slab gels containing 4.5% (stacking gel) and 10% (separating or 
running gel) acrylamide were prepared from a stock solution of 29.2% (w/v) 
acrylamide and 0.8% (w/v) N,N’-methylenebisacrylamide. Final concentrations 
in the separating gel were as follows; 10% (w/v) acrylamide, 0.375 M 
Tris-HCl (pH 8.8), 0.1% (w/v) sodium dodecyl sulphate (SDS), 0.05% (v/v)
N, N,N*,N'-tetraethylmethylenediamine (TEMED) and 0.33% (w/v) ammonium 
persulphate. The gels were poured to within 2 cm of the top of the plate, 
overlayed with water and allowed to polymerise for 1-2 hours. The 
stacking gel consisted of; 4.5% (w/v) acrylamide, 0.125 M Tris-HCl (pH 6.8)
O. 1% (w/v) SDS, 0.06% (v/v) TEMED and 0.029% (w/v) ammonium persulphate.
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Sample channels were created in the stacking gel by the presence of a 
teflon "comb" containing eight 1 cm wide "teeth". Polymerisation of the 
stacking gel generally took 2-3 hours. The electrode buffer contained 
0.25 M Tris-HCl, 0.192 M glycine, and 0.1% (w/v) SDS (pH 8.3).
Solubilising buffer contained 0.01 M phosphate (pH 7.1), 5% (w/v)
SDS, 10% (v/v) 2-mercaptoethanol and 10% (w/v) sucrose (Glossman and Lutz, 
1970). Lyophilised membrane samples were dissolved in the solubilising 
buffer by heating at 100°C for 3 minutes. Aliquots containing between 
30 and 80 yg protein were applied to individual channels and electrophoresis 
was carried out with a current of 35 mA. Running time varied from 3 to 4 
hours and was followed by the frontal movement of the tracking dye, 
bromophenol blue.
The gels were fixed in 10% (v/v) isopropyl alcohol and 10% (w/v) 
trichloroacetic acid for 1-2 hours. These were then stained overnight in 
a 50% (v/v) methanol and 10% (v/v) acetic acid containing 0.1% (w/v) 
Coomassie brilliant blue. The gels were diffusion destäined by exhaustive 
washing in 10% (v/v) acetic acid and 5% (v/v) methanol solutions and stored 
in 10% (v/v) acetic acid. Electrophoresis was carried out in a unit 
constructed to published specifications (Madjar et al. , 1977) with the 
exception that no cooling facilities were built into the apparatus. The 
preparation of the acrylamide gels represents a modified version of the 
method published by Laemmli (1970).
The protein stained gels were photographed and densitometric scans 
obtained of the prints. Densitometry was performed on a model SD 3000 
Spectrodensitometer (Schoeffel Instrument Corp.) equipped with a model 300 
density computer. Scans were performed at 550 nm using a single beam mode
of reference.
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3.2.8 Lipid analysis
Membrane suspensions were lyophilised and extracted overnight 
in 10 ml of chloroform/methanol (2/1; v/v). These samples were filtered 
through Whatman 41 filter paper into preweighed graduated glass tubes and 
the filtrate was aqueous washed (Folch et al. , 1957). Aliquots were 
removed for cholesterol (Owens and Hughes, 1970) and total lipid 
phosphorus (Bartlett, 1959) determinations and the remaining lipid was 
dried under nitrogen. Total lipid content was determined gravimetrically. 
Neutral and polar lipid separation was achieved by thin layer chromatography 
(TLC) on 0.25 mm thick silica gel G plates in a hexane:diethylether:acetic 
acid (90:10:1; v/v/v) solvent system (De Moreno et al. , 1976). The 
phospholipid bands were visualised by spraying with 0.1% (w/v) 2,7- 
dichlorofluorescein in 95% methanol and were methylated in 14% (w/v) boron 
trifluoride-methanol at 100°C for 10 minutes (Morrison and Smith, 1964).
The methylated fatty acids were extracted into hexane and analysed by gas 
liquid chromatography (GLC). Analysis of the methylated fatty acids was 
performed on a Packard 7300 gas chromatograph equipped with a model 805 
oven.
The glass column (180 cm by 4 mm i.d.) was packed with 10% DEGS-PS 
on 80/100 mesh Supelcoport (Supelco Inc.) and operated at 190°C. Injection 
and detection ports were maintained at 225°C and gas flow rates were as 
follows; N2 , 20 ml/minute; H2 , 20 ml/minute and air, 200 ml/minute. An 
inlet column pressure of 20 psi was maintained at the injection port.
Peak identification was referenced against known standards (PUFA 1 and 2; 
Supelco Inc.) and log plots of retention time versus carbon number were 
used to confirm identification. A Mini Lab digital integrator (Columbia 
Scientific Instruments) was used for peak quantitation.
All lipid values are reported as means ± S.D.
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3.2.9 Materials
Sucrose, SDS, ammonium persulphate, glycine, bromophenol blue, 
and boron trifluoride were obtained from British Drug Houses. Silica 
gel-G was from Merck, azaperone from Ethnor and TEMED from Koch-Light 
Laboratories. Coomassie brilliant blue, dichlurofluorescein., and trizma 
base were obtained from Sigma Chemical Company and acrylamide, N,N’- 
methylenebisacrylamide and 2-mercaptoethanol were from Eastman. Additional 
reagents (i.e. buffer salts, scintillation reagents etc.) were obtained 
from British Drug Houses.
3.3 RESULTS
3.3.1 Buoyant density patterns
Figure 3.2 illustrates the density gradient pattern of normal 
skeletal muscle microsomes from trapezius and 1. dorsi muscles. The 
fractions designated as light, heavy and sediment correspond to material 
banding at 8-30%, 30-45% interfaces and at the bottom of the tube, 
respectively. Similar patterns were obtained for both MH muscles. The 
variable occurrence of light material in 1. dorsi muscles was a feature 
of both normal and MH muscles. Halothane anaesthesia failed to alter this 
gradient fractionation pattern in either normal or MH muscles.
3.3.2 Electron microscopy
Representative electron micrographs of the various microsomal 
fractions are shown in Figures 3.3 and 3.4. Micrographs of the crude 
microsomal material and of the sediment fractions are not shown but in 
both cases contractile protein contamination was evident. Vesicular 
material accounted for at least 70% of the former material.
Light vesicles isolated from normal (Figure 3.3a) and MH (Figure 3.3b)
Figure 3.2: Buoyant density pattern of normal porcine skeletal
muscle microsomes in discontinous density gradients
The gradient consisted of 8%, 30% and 45% (w/v) sucrose.
Centrifugation was for 2 hours at 96,000 g. Buoyant density
patterns of normal trapezius (a) and 1. dorsi (b) microsomes are
shown. MH muscles displayed similar buoyant density patterns.
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Figure 3.3: Electron micrographs of microsomal membranes from
normal and MH trapezius muscle
Micrographs of light (A) and MH (B) microsomal vesicles and of 
heavy normal (C) and MH (D) microsomal vesicles are shown. 
T-tubular material is indicated by single arrows and mitochondria 
by double arrows. The bar line represents 500 nm.
4:
Figure 3.4: Electron micrographs of microsomal membranes from
normal and MH 1. dorsi muscles
Micrographs of light normal (A) and MH (B) microsomal vesicles, 
and of heavy normal (C) and MH (D) microsomal vesicles are shown. 
T-tubular material is indicated by single arrows and mitochondria 
by double arrows. The bar line represents 500 nm.
4 <
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trapezius muscle displayed many common features including closed vesicles 
of variable size, an absence of mitochondria and an absence of electron 
dense material within the vesicles.
The heavy vesicles isolated from normal (Figure 3.3c) and MH 
(Figure 3.3d) trapezius muscle were characterised by the predominance of 
variable sized vesicles, some mitochondria (double arrows in Figure 3.3), 
the presence of T-tubular material (single arrows in Figure 3.3) and the 
presence of electron dense material within many of the vesicles.
The light banding material from both normal (Figure 3.4a) and MH 
(Figure 3.4b) 1. dorsi muscle, displayed characteristics similar to those 
described for light microsomes from trapezius muscle (Figure 3.3a and b). 
Mitochondrial contamination was more extensive and T-tubular material less 
evident in heavy 1. dorsi microsomes (Figure 3.4c and d) than in trapezius 
heavy microsomes (Figure 3.3c and d) but as with the other microsomal 
fractions vesicular material predominated.
Halothane treated normal and MH muscle fractions were not analysed 
by electron microsopy.
3.3.3 Ouabain binding
An average of 1% (0.33-1.25%) of the total ouabain injected was 
recovered in the crude microsomal fraction, with MH microsomes binding 
twice (3.8 pmoles, n = 2) as much as normal (1.8 pmoles, n = 2) microsomes. 
Arbitrarily setting the amount of ouabain bound by the light microsomal 
fractions equal to 1, then ratios of 1, 3.4 and 6.7 and 1, 3.5 and 2.4 
were obtained for the light, heavy and sediment fractions of normal and MH 
1. dorsi muscles, respectively. In normal muscle, of the 1.8 pmoles of 
bound ouabain applied to the gradient, 6%, 18% and 38% was recovered in the 
light, heavy and sediment fractions, respectively. Of the 3.8 pmoles of
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ouabain bound by the MH crude microsomal fraction, 9%, 30% and 20% were 
bound by the light, heavy and sediment fractions, respectively. Thus, in 
these limited experiments both qualitative and quantitative differences 
characterised ouabain binding in normal and MH 1. dorsi muscles.
3.3.4 Protein analysis
Quantitative recovery of muscle membranes was not attempted in this 
study, hence no attempt was made to correlate membrane protein recovery 
per amount of muscle homogenised. The generally low yield (in terms 
of protein) of light microsomal material from normal and MH 1. dorsi 
muscles resulted in only limited analysis being carried out on these 
fractions. Therefore only electron microscopic and protein electrophoretic 
analysis were consistently carried out on the 1. dorsi light microsomal 
material.
3.3.5 Amino acid composition
Total hydrolysis of the individual fractions yielded the amino 
acid compositional profiles shown in Table 3.1. The high occurrence of 
acidic amino acids (i.e. glutamic and aspartic acids) was a feature in all 
samples and the % contribution of individual amino acids was 
similar in all fractions.
The low occurrence of glycine (<9%) is indicative of minimal 
contamination by collagen and other connective tissue-like proteins. The 
sulphur containing amino acid cysteine is destroyed in the hydrolytic step 
employed for this analysis and separate attempts were not made to assess 
its relative contribution. Amino acid analysis was not performed on either
halothane treated normal or MH fractions.
normal and MH porcine skeletal muscles
Table 3.1: Amino acid composition of sub-cellular fractions of
Residues per 100 Total Amino Acids*
Trapezius Trapezius L. Dorsi L. Dorsi
Normal MH Normal MH
Amino Acid Light Heavy Light Heavy Heavy Heavy
Aspartic Acid 9.8 10.1 10.7 10.6 9.2 10.0
Threonine 5.0 5.8 5.6 5.8 5.6 5.5
Serine 6.4 6.4 7.1 6.7 5.9 6.7
Glutamic Acid 13.2 13.1 12.1 11.6 13.3 13.6
Proline 5.1 5.2 3.6 4.1 5.4 6.4
Glycine 8.9 8.8 8.9 8.7 8.9 8.9
Alanine 8.9 8.5 8.5 8.7 8.9 8.9
Valine 6.4 6.1 6.5 6.5 6.4 6.1
Methionine 1.9 1.3 2.0 1.9 2.3 2.1
Isoleucine 5.2 4.6 4.5 4.6 5.0 4.6
Leucine 9.1 9.3 9.6 9.7 8.8 8.5
Tyrosine 2.6 2.9 2.5 2.8 3.1 2.7
Phenylalanine 4.1 3.9 4.0 4.2 4.0 3.8
Lysine 6.7 6.8 7.1 7.1 6.4 6.0
Histidine 2.6 2.3 2.4 2.4 2.0 1.9
Arginine 4.5 4.8 4.9 5.1 4.9 4.5
Values are reported as means (n = 3)1
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3.3.6 Protein SDS acrylamide gel analysis
Molecular weight standardisation of the 10% acrylamide gels used 
in this study was achieved with the use of the known molecular weight 
standards shown in Figure 3.5. Molecular weight assignments for 10% 
acrylamide gels are reliable within the 95,000 to 20,000 molecular weight 
range, as it is only within this range that the straight line relationship 
between the log of the molecular weight and protein mobility is linear 
(Figure 3.5).
The large number of proteins was a feature of the light and heavy 
fractions from both muscle types in normal and MH microsomes. Figure 3.6 
(a and b) shows sample gels and their respective densitometric scans of 
trapezius light microsomal proteins isolated from normal and MH muscles, 
respectively. The comparable light 1. dorsi fractions are shown in Figure 
3.6a and b for normal and MH muscle, respectively. Quantitative differences 
were apparent between the normal and MH fractions of both muscle types but 
such differences were of a variable nature. The protein profiles of the 
heavy microsomal membranes are shown in Figure 3.7 and as for the light 
microsomal proteins quantitative rather than qualitative differences were 
apparent. Sediment fractions (Figure 3.8) displayed the characteristic 
myosin (molecular weight 200,000) and actin (molecular weight 43,000) 
proteins, indicating that in these samples contractile protein contamination 
was extensive. Apparent differences in densitometric scans are primarily 
due to variable sample application with samples b and d (Figure 3.8) being 
overloaded.
The sample gels shown represent muscle fractions which were 
scanned under identical conditions. Variations in the width and length of 
the scanning beam affect resolution in densitometry but in these sample 
gels this factor has been minimised. As many of the samples (not shown)
Figure 3.5: Electrophoretic mobility as a function of molecular
weight
Molecular weight on a log scale is plotted against relative 
mobility for a standard mix of proteins. These included: 
3-galactosidase (120,000), phosphorylase A (93,000), bovine serum 
albumin (67,000), catalase (60,000), glutamate dehydrogenase 
(53,000), ovalbumin (43,000), alcohol dehydrogenase (37,000), 
triosephosphate isomerase (26,500), adenylate kinase (23,000), 
ribonuclease A (13,500) and cytochrome c (12,000). Electrophoresis 
and staining were carried out as described in Section 3.2.7.
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membranes from normal and MH skeletal muscles
Representative patterns of light microsomal proteins from normal
(A) and MH (B) trapezius and normal (C) and MH (D) 1. dorsi muscles
are shown. Molecular weight standards are indicated by arrows and
from left to right comprise: phosphorylase A (93,000), bovine serum
albumin (67,000), ovalbumin (43,000) and adenylate kinase (23,000).
Sample solubilisation, electrophoresis, staining, and densitometry
Figure 3.6: Polyacrylamide gel patterns of light microsomal
were carried out as described in Section 3.2.7.
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Figure 3.7: Polyacrylamide gel patterns of heavy microsomal
membranes from normal and MH skeletal muscles
Representative patterns of heavy microsomal proteins from normal
(A) and MH (B) trapezius and normal (C) and MH (D) 1. dorsi muscles
are shown. Molecular weight standards are indicated by arrows and
from left to right comprise: phosphorylase A (93,000), bovine serum
albumin (67,000), ovalbumin (43,000) and adenylate kinase (23,000).
Sample solubilisation, electrophoresis, staining, and densitometry
were carried out as described in Section 3.2.7.
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Figure 3.8: Polyacrylamide gel patterns of sediment fractions
from normal and MH skeletal muscles
Representative patterns of sediment proteins from normal (A) and 
Mil (B) trapezius and normal (C) MU (D) 1. dorsi muscles are shown. 
Molecular weight standards are indicated by arrows and from left to 
right comprise: phosphorylase A (93,000), bovine serum albumin
(67,000), ovalbumin (43,000) and adenylate kinase (23,000). Sample 
solubilisation, electrophoresis, staining, and densitometry were 
carried out as described in Section 3.2.7.
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were scanned over a six month period the variation in protein profiles 
may be partially caused by alterations in scanning conditions.
In a number of MH microsomal fractions the diminished occurrence 
of a low molecular weight protein distinguished susceptible from normal 
muscles and this deficiency was found in both trapezius and 1. dorsi 
muscles. This feature is illustrated in Figure 3.7 where the absence of 
this protein (molecular weight 20-25,000) in the heavy MH fraction from 
1. dorsi muscle contrasts with its presence in the equivalent fraction 
from normal muscle.
Halothane anaesthesia failed to modify the protein profiles of 
either normal and MH muscle microsomes in a consistent manner but a 
quantitative decrease in a number of densitometric peaks in some halothane 
treated MH muscle fractions might reflect a generalised loss of peripherally 
attached membrane proteins (gels and scans not shown).
3.3.7 Lipid composition 
a) Light microsomes
Light microsomes isolated from normal and MH trapezius muscle 
yielded total lipid to protein (w/w) ratios of 1.15 ± 0.29 (n = 10) and 
0.94 ± 0.25 (n = 8), respectively. Cholesterol content was similar in 
both, but there was a significant decrease (p < 0.05) in the lipid phosphorus 
content in the light microsomal fraction isolated from MH trapezius muscle 
(Table 3.2). In the light MH fraction the cholesterol to lipid phosphorus 
ratio was approximately double that found in normal muscle (Table 3.2).
The low occurrence of light microsomal material from normal and MH 1. dorsi 
muscle was a consistent feature and was probably indicative of a heavier 
banding surface membrane which, because of the limited number of density 
"steps" in the gradient, banded with the bulk of the microsomal material at
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normal muscle ( pre-halothane ) 
M H  muscle ( pre-halothane )
M H  muscle ( post-halothane )
FATTY ACID TYPE
Figure 3.9: Polar fatty acid composition of the light microsomal
fraction from normal and MH trapezius muscles
The mean percentage (±S.D.) of individual fatty acids are shown. Fatty
acids contributing less than 5% are excluded. Two comparisons have been
made (a) MH muscle pre-halothane with normal muscle pre-halothane
(significance values are represented by *); and (b) MH muscle post-halothane
with MH muscle pre-halothane (significance values are indicated by*).
* p<0.05 * p < 0.05
*** p < 0.001
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normal muscle ( pre-halothane ) 
M H  muscle ( pre-halothane ) 
M H  muscle ( post-halothane )
FATTY ACID TYPE
Figure 3.10: Polar fatty acid composition of the heavy microsomal
fraction from normal and MH trapezius muscles
The mean percentage (±S.D.) of individual fatty acids are shown. Fatty
acids contributing less than 5% are excluded. Two comparisons have been
made (a) MH muscle pre-halothane with normal muscle pre-halothane
(significance values are represented by *); and (b) MH muscle post-
halothane with MH muscle pre-halothane (significance values are indicated
by * ).
* * * p < 0.01 ★ p < 0.05
★ p < 0.001
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normal muscle ( pre-halothane ) 
M H  muscle (pre-halothane)
M H  muscle ( post-halothane )
FATTY ACID TYPE
Figure 3.11: Polar fatty acid composition of the heavy microsomal
fraction from normal and MH 1. dorsi muscles
The mean percentage (±S.D.) of individual fatty acids are shown. Fatty 
acids contributing less than 5% are excluded. Two comparisons have been 
made (a) MH muscle pre-halothane with normal muscle pre-halothane 
(significance values are represented by *); and (b) MH muscle post- 
halothane with MH muscle pre-halothane (no significant differences were 
found in this group).
* p < 0.05
60
the 30-45% interface. Phospholipid fatty acid composition of the 
trapezius light fraction is shown in Figure 3.9. A significant increase 
in the palmitic acid (C16:0) content (p < 0.05) and a decrease in the 
linoleic acid (Cl8:2) content (p < 0.001) were a feature of light microsomal 
phospholipids from MU trapezius muscle.
There were no significant differences in light microsomal lipid, 
cholesterol or lipid phosphorus contents after halothane anaesthesia 
(Table 3.2) indicating that the lipid compositional profiles of normal 
and MH muscle are not grossly altered by a one hour halothane challenge.
The decrease in arachidonic acid (C20:4) levels was the only significant 
change that occurred in MH light microsomal membrane composition in response 
to halothane anaesthesia (Figure 3.9).
b) Heavy microsomes
Total lipid and lipid phosphorus content of heavy microsomal 
fractions from trapezius muscle was significantly lower (p < 0.01) than 
in normal heavy microsmal fractions (Table 3.3A). Cholesterol levels 
were similar (Table 3.3A) in both normal and MH heavy microsomal fractions 
and with the exception of linoleic acid (C18:2) phospholipid fatty acid 
composition was essentially similar (Figure 3.10).
Lipid composition of normal and MH 1. dorsi heavy microsomal 
fractions was similar (Table 3.3B). The levels of oleic acid (C18:l) 
were lower in MH heavy microsomes (Figure 3.11) and this represented the 
only statistically significant difference in lipid composition between 
normal and MH 1. dorsi heavy microsomal fractions.
Table 3.3A and Figure 3.10 summarise the effects of halothane 
anaesthesia on MH trapezius heavy microsomal lipid composition. Total 
lipid contentwas increased (before halothane = 0.40 ±0.07; after halothane
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= 0.64 ± 0.16; p < 0.01, Table 3.3A) and there was a significant increase 
(p < 0.01) and decrease (p < 0.05) in the levels of palmitic (C16:0) 
and arachidonic (C20:4) acids, respectively, after halothane treatment 
(Figure 3.10).
No changes were recorded in the lipid composition of MH 1. dorsi 
heavy microsomes isolated before and after halothane anaesthesia (Table 
3.3B and Figure 3.11). Halothane anaesthesia also had little effect on 
membrane lipid composition for both normal trapezius and 1. dorsi muscles 
(results not shown).
The lipid data from the sediment fractions are shown in Table 3.4.
Due to extensive contamination by non-membranous material no attempt has 
been made to statistically analyse the data and it has been included merely 
for comparative purposes. In a number of sediment fractions phospholipid 
fatty acid profiles were also determined but as the compositional distribution 
reflected that found in the light and heavy microsomal fractions it has not 
been included here.
3.4 DISCUSSION
A major aim of this study was the development of a mild and 
reproducible fractionation procedure for porcine skeletal muscle microsomes 
which avoided the use of high salt solutions, hypotonic solutions or 
incubations at elevated temperatures. These latter procedures are used 
in most skeletal muscle membrane fractionation schemes. This seemed a 
prerequisite for experiments designed to structurally and functionally 
characterise muscle membranes from a normal and myopathic source. The 
methods described here fulfil this aim and their application to both red 
and white muscles from normal and MH swine has provided data on the nature
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of the structural abnormality in MH muscle membranes.
The identification of muscle microsomal fractions was carried out 
on the basis of electron microscopic and chemical compositional 
characteristics. In the case of 1. dorsi muscle the binding of tritiated 
ouabain also permitted the tracking of T-tubular material (Caswell et al. ,
1976) during the fractionation process. The high cholesterol/protein and 
total lipid/protein ratios in the light fractions are characteristic 
features of the muscle sarcolemma (Fiehn et al. , 1971; Schapira et al. ,
1976; Agapito and Cabezas, 1977; Headon et al. , 1977; Somer et al. , 1977). 
The diminished occurrence of light banding material from 1. dorsi muscle 
indicates that in this muscle sarcolemmal membranes band at heavier 
densities. Similar observations have been made on the rat extensor 
digitorum longus muscle which, like the porcine 1. dorsi muscle, is a
white muscle (Smith and Appel, 1977). Light banding material from rabbit 
muscle also bands at this density (i.e. 30% sucrose) in continuous gradients 
and this material has been proposed to constitute SR membrane vesicles 
which are "inside-out" (Sarzala and Michalak, 1978). Thus the light vesicle 
fraction characterised in the present study probably constitutes membrane 
material which originates from the sarcolemma (Kidawi, 1974) and the SR 
(Meissner, 1975; Sarzala and Michalak, 1978).
The lower total lipid/protein and cholesterol/protein ratios 
observed in the heavy vesicle fractions were consistent with their heavier 
banding position on the gradient (McIntosh et al. , 1977) and indicate that 
the bulk of this membrane material was intracellular in origin (Headon et al. ,
1977) .
The differences in buoyant density profiles obtained were 
characteristic of the type of muscle used (i.e. red or white) and failed to
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distinguish normal from MH muscles. T-tubular entrapment of tritiated 
ouabain (Caswell et at. , 1976) was qualitatively and quantitatively 
different in normal and MU 1. dorsi muscles and a proliferation of the 
junctional tubular system, as has recently been demonstrated in dyst ophic 
muscle (Scales et at., 1977; Crowe and Baskin, 1979) might explain the 
increased capacity of MH 1. dorsi muscle to bind ouabain. It is possible, 
therefore, that hypersensitive E-C coupling which is an in vitro 
pharmacological feature of MH muscle (Okumura et at. , 1980) may simply 
reflect such a proliferation of the tubular membrane system. This 
possibility remains to be fully explored.
Electron microscopy provided additional evidence favouring the 
notion that all light and heavy fractions constituted predominantly vesicular 
membrane material. A heterogeneous size and shape distribution were 
characteristic features of normal and MH light and heavy fractions from 
both muscle types, indicating that these physical parameters were of limited 
importance in determining vesicle buoyancy in sucrose density gradients. 
Tentative identification of the skeletal muscle site of origin of the 
vesicle-like material was attempted only for mitochondria and T-tubular 
material and identification was based on published micrographs (Kidawi 
et at., 1973; Kidawi, 1974; Caswell et at., 1976; Lau et at., 1977).
The preferential localisation of porcine mitochondrial and T-tubular 
material in the heavier banding fraction accords with the banding position 
of this material from rat and rabbit skeletal muscle (Kidawi et at. , 1973; 
Caswell et at., 1976). The remaining vesicular material, constituting the 
bulk of both the light and heavy fractions, probably originated from the 
terminal cisternae and from the longitudinal sections of the SR (Meissner, 
1975). Furthermore Meissner (1975) has proposed that the light and heavy 
banding vesicles might be preferentially derived from the longitudinal
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sections and terminal cisternae of SR, respectively, but it is unknown if 
such a distribution characterises the vesicle fractions isolated in the 
present study.
Amino acid compositional data have been used in a number of studies 
of muscle membranes (Martonosi and Halpin, 1971; Vandenburgh et al. , 1974) 
and these data provide a useful indicator of connective tissue contamination. 
The high occurrence of glycine and proline indicates that the membrane 
preparation isolated by Vandenburgh et at. (1974) contained extensive 
amounts of collagen-like proteins. The results obtained in the present 
study closely reflect the amino acid compositional profile of rabbit SR 
(Martonosi and Halpin, 1971) and in both of these studies the low occurrence 
of glycine and proline indicates that contamination with connective tissue 
proteins was minimal.
The SDS gel electrophoresis study showed that quantitative rather 
than qualitative differences characterise the various microsomal fractions 
but the variable nature of these differences restricted any detailed 
comparisons.
The complexity of the membrane protein acrylamide gel patterns 
contrasts with most published reports on muscle membranes (McIntosh et al. , 
1977; Lau et al. , 1977; Smith and Appel, 1977) and may reflect differences 
in isolation and electrophoretic conditions or cross contamination with 
different membrane fractions.
The similarity in membrane protein compositions between the red and 
white fractions characterised here agrees with published data on rat red 
and white muscle microsomes (Smith and Appel, 1977) but contrasts with the 
differences reported to exist betwen red and white microsomal proteins in 
porcine 1. dorsi muscle (McIntosh et al. , 1977). Normal and MH
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microsomes were essentially similar in qualitative protein content and it 
would seem that the abnormal functioning that characterises MH muscle is 
not related to gross changes in membrane protein constituents. The 
quantitative differences may in themselves reflect MH susceptibility but 
their variable occurrence tends to downplay such a possibility.
Significant differences were found in the lipid composition of 
MH trapezius fractions with increased cholesterol and decreased lipid 
phosphorus values being a consistent feature in all the trapezius fractions 
analysed. The decrease of linoleic acid content in MH trapezius muscle 
membranes is in line with the above observations on cholesterol and lipid 
phosphorus contents and indicates that in MH swine the red trapezius muscle 
is in a more solid or rigid state. Thus on exposure to halothane the 
membranes may become abnormally fluid (Austin, 1976). The inability to 
detect similar differences in the white 1. dorsi muscle questions the 
generality of this change in membrane lipid composition in MH, and of its 
importance in explaining its aetiology. Abnormal drug-induced contractures 
are an in vitro feature of the white gracilis (Okumura et dl. , 1979) and 
the red trapezius (B. Crocker, J. Sullivan and M.A. Denborough, unpublished 
results) muscles, indicating that the abnormality is expressed irrespective 
of muscle fibre type. It is possible that the lipid changes described in 
MH trapezius muscle may be a secondary event and may reflect changes in 
fibre type distribution. The differences described in phospholipid fatty 
acid profiles of the normal red trapezius and the white 1. dorsi muscles, 
contrast with evidence presented on phospholipid fatty acid composition in 
red and white segments of procine 1. dorsi muscle (McIntosh et at. , 1977). 
Possible contamination with adipose material (Takagi et at. , 1973) may 
have contributed to the differences observed in lipid composition of normal 
and MH trapezius muscle microsomes.
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The inability to detect consistent lipid and/or protein 
compositional differences in the crude microsomal fractions characterised 
in the present study suggests that (1) the lipid and protein content of 
MH muscle microsomes is not grossly abnormal and (2) a further purification 
of the microsomal fractions is required to properly assess whether a 
consistent compositional abnormality is present in specific MH skeletal 
muscle membranes (e.g. T-tubule membrane).
3.5 SUMMARY
Discontinuous sucrose density gradient centrifugation was employed 
to isolate discrete light and heavy banding microsomal fractions from 
normal and MH porcine skeletal muscles. These fractions were characterised 
with respect to lipid and protein content. Differences in lipid 
composition were apparent only in the red trapezius muscle, where an increase 
in cholesterol and a decrease in phospholipid unsaturated fatty acid content 
characterised the MH trapezius muscle. The similar lipid compositional 
profiles for normal and MH white 1. dorsi muscles suggests that the lipid 
changes observed in MH trapezius may reflect a secondary pathological event. 
Consistent differences in membrane protein content were not apparent in any 
of the muscle fractions analysed although variable protein differences were 
observed in the low molecular weight range. It is suggested that gross 
changes in lipid and protein content do not characterise MH muscle membranes.
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CHAPTER 4
NUCLEAR MAGNETIC RESONANCE STUDIES OF 
ANAESTHETIC-MEMBRANE INTERACTIONS
4.1 INTRODUCTION
4.1.1 Theories of anaesthesia
"General anaesthesia is a pharmacologically induced reversible 
disruption resulting in a coordinated sequence of changes in neural 
activity" (Kaufmann, 1977). The clinical value of anaesthetics derives 
from their ability (at low concentrations) to reversibly impair higher 
neural functions without seriously disrupting the functions of the 
cardiovascular and respiratory systems. The molecular mechanisms under­
lying the complex processes of anaesthesia largely remain a mystery. 
Nonetheless, four key observations suggest that anaesthesia is the result 
of a physical interaction between the anaesthetic and certain constituents 
of the cell rather than a specific chemical reaction. First, the in vivo 
and in vitro (Mastrangelo et al., 1978) reversibility of anaesthetic 
action; second, the potency of an anaesthetic is related to its lipid 
solubility (Meyer, 1937); third, anaesthetic properties are shown by a 
wide variety of simple but chemically unrelated substances (Miller, 1977) 
and fourth the effects of anaesthetics can be reversed by high pressures 
(Seeman, 1977). The site of this "physical interaction" is generally 
considered to be membrane localised (Miller, 1977; Trudell, 1977).
Hydrophobic (apolar) and hydrophilic (polar) environments 
characterise specific regions in biological membranes (Singer, 1972;
Singer and Nicolson, 1972) and the predominance of chemically neutral 
anaesthetics (e.g. nitrous oxide, cyclopropane, halothane etc.) has led
to the recognition that predominantly hydrophobic forces are involved 
in anaesthetic action (Miller, 1977). Candidates for this anaesthetic 
"site” are the phospholipid moieties of the membrane bilayer which 
constitutes an integral part of all biological membranes. This does not 
rule out hydrophilic interactions between the anaesthetic and specific 
membrane constituents (Sandorfy, 1978); such mechanisms of anaesthesia 
have not been as extensively studied. Theories of anaesthesia which address 
themselves to the lipid bilayer as the primary site of action of 
anaesthetics, represent elaborations on the "critical volume" hypothesis 
(Mullins, 1954; Seeman, 1972; Kaufmann, 1977; Miller, 1977). The 
"critical volume" hypothesis proposes that it is not the concentration of 
anaesthetic within the membrane, but the anaesthetic-induced expansion in 
membrane volume that actually causes anaesthesia (Miller, 1977).
The most simple of these, the "fluidised lipid" hypothesis, 
proposes that the interaction of the anaesthetic with membrane results 
in a generalised increase in lipid fluidity or mobility (Trudell et al. , 
1973). The "lateral phase separation" hypothesis (Trudell, 1977) 
represents a refinement of the "fluidised lipid" hypothesis in that it 
postulates that anaesthetics "melt" or fluidise a region of co-existing 
liquid-like and solid-like lipid surrounding a membrane protein, thus 
reducing the protein's ability to undergo conformational changes 
associated with normal functioning. Major determinants of membrane 
fluidity include the degree of unsaturation, the chain length and the 
head group specificity of component phospholipids, the cholesterol 
content and the temperature (Emmelot and Van Hoevan, 1975; Marsh, 1975) 
and these factors may in turn modulate the effects anaesthetics have on 
biological membranes (Pang and Miller, 1978).
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The "phase transition" hypothesis (Lee, 1976) represents an 
additional variation on this common theme and, although initially 
developed to explain the mode of action of local anaesthetics, it is 
also applicable to general anaesthetics. The annular lipids surrounding 
specific membrane proteins are proposed to be in a solid state and the 
addition of the anaesthetic "melts" this lipid with a resultant decrease 
in the activity of these proteins (Lee, 1976, 1979).
The "plate" model of membrane structure proposes that the 
biomembrane is composed of a number of relatively rigid plates or patches 
(composed of phospholipids in a crystalline or solid state) that are in 
relative motion with respect to each other (Jain and White, 1977). These 
rigid plates constitute discrete cooperative units which are separated 
from each other by relatively fluid, disorganised phospholipid regions. 
Anaesthetics reduce the size of the cooperative unit in membranes, thus 
altering the physical environment of its constituent functional proteins 
(Koehler et al. , 1978).
The assumption that the primary site of action of anaesthetics 
is the phospholipid of the membrane, is a common feature in the "fluidised 
lipid", the "lateral phase separation", the "phase transition" and the 
"cooperative plate" theories of anaesthesia (discussed above). The 
interaction of the anaesthetic with the phospholipid portions of the 
bilayer is somehow "felt" by the functional proteins in the membrane and 
therefore the effects of anaesthetics are mediated by this indirect effect 
on membrane proteins (Miller, 1977; Lenaz et al. , 1978a, b). The 
mechanism by which this indirect effect of anaesthetics is mediated 
differs in each of the lipid-based theories outlined above but all propose 
that labilisation of lipid-protein interactions is the end result of this
"indirect" effect.
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The presence of discrete hydrophobic and hydrophilic zones in 
membrane proteins is a central tenet of the fluid mosaic model of membrane 
structure (Singer and Nicolson, 1972) and therefore a direct interaction 
between the anaesthetic and the hydrophobic regions of the protein cannot 
be ruled out as a primary site of anaesthetic action. Evidence in favour 
of such a direct anaesthetic-protein interaction stems from studies on 
the effects of anaesthetics on isolated protein structure (Balasubramanian 
and Wetlaufer, 1966; Barker et at., 1975; Sachsenheimer et at. , 1977) 
and function (Ueda and Kamaya, 1973). The failure of anaesthetics to 
inhibit solubilised red blood cell acetylcholinesterase at concentrations 
which readily inhibit the membrane bound enzyme argues against such a 
direct interaction (Lenaz et at. , 1978a).
The resume of the proposed mechanisms by which anaesthetics exert 
their effects is by no means complete. It is biased towards those 
theories which have the lipid bilayer as the primary site of action of 
anaesthetics. This bias reflects the majority held view that the anaesthetic 
site is lipid localised. The next section considers the contribution 
biophysical techniques, especially nuclear magnetic resonance (NMR) 
spectroscopy, have made to our understanding of the mechanisms of anaesthesia.
4.1.2 Biophysical studies of anaesthetic-membrane interactions
The molecular events which follow the binding of anaesthetics 
to membrane components lie at the heart of anaesthetic action. A number 
of biophysical techniques have been used to study the mechanisms of action 
of anaesthetics including fluorescence spectroscopy (Okuda and Ogli, 1979), 
differential scanning calorimetry (Jain et at., 1975; Koehler et at., 1978), 
X-ray and neutron diffraction (Franks and Lieb, 1978, 1979), electron spin 
resonance spectrocopy (Trudell et at. , 1973; Boggs et at. , 1976; Miller
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and Pang, 1976; Rosenberg et al. , 1977; Lenaz et al. , 1978a, b;
Mastrangelo et al. , 1978; Pang and Miller, 1978) and NMR spectroscopy 
(Shieh et al. , 1975, 1976; Trudell and Hubbell, 1976; Koehler et al. ,
1977a, b; Vanderkooi et al. , 1977; Koehler et al. , 1978, 1979). With 
few exceptions (see Boggs et al. , 1976; Franks and Lieb, 1978, 1979) 
these studies implicate the lipid bilayer as the primary site of 
anaesthetic action. In principle, NMR spectroscopy represents the most 
useful of these biophysical approaches in that it is non-perturbing and 
can supply detailed molecular information on a number of naturally occurring, 
biologically important nuclei (e.g. 1H, 13C, 19F and 31P). Details 
regarding the theory of NMR are outside the scope of this study but suffice 
it to say that certain nuclei are characterised by a magnetic moment which 
in the presence of an externally applied magnetic field can be manipulated 
to obtain information regarding the molecular environment of the nucleus.
In this study the functional characterisation of anaesthetic-membrane 
interactions has been carried out using 1^, 19F and 31P NMR spectroscopy.
The effects of halothane on muscle membranes has been examined using 1H NMR 
and some aspects of halothane membrane interactions have been studied in 
artificial lipid membranes using 31P and 19F NMR. This latter approach 
has permitted monitoring of lipid and anaesthetic environments in the 
same sample.
4.2 MATERIAL AND METHODS 
4.2.1 Methods 
a) ltt NMR
Muscle membrane fractionation and the preparation of total 
lipid extracts were carried out as described in Sections 3.2.3 and 3.2.8, 
respectively. Fractions were lyophilised and reconstituted in a glucose
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free, modified D20-Ringer buffer (121 mM NaCl, 5.4 mM KC1, 1.2 mM MgS04,
1.2 mM NaH2P04, 15 mM NaHC03, 2.5 mM CaCl2 in D20; pH 7.1-7.2).
Sonication of muscle membrane fractions was not employed but total lipid 
extracts were sonicated as described for egg lecithin preparation (see 
below). Egg lecithin (L-a-phosphatidylcholine; henceforth referred to 
as EPC) and EPC-cholesterol vesicles were formed by sonication at maximum 
output for 15 minutes in an MSE 100 watt ultrasonic disintegrator (MSE 
Ltd, London, England). During sonication the lipid suspensions were kept 
on ice. Standard concentrations of EPC (50 mg/ml) and cholesterol 
(12.5 mg/ml) were always used. Vortexed lipid samples were prepared by 
intermittent mixing (5-10 minutes total duration) on a model K-500J vortex 
mixer (Scientific Industries Inc. Mass. U.S.A.). NMR spectra were 
obtained on a JOEL NMH-100, continuous wave spectrometer operating at 
100 MHz. Ambient probe temperature was 26°C and all spectra were obtained 
by a single sweep of 250 seconds over 1080 Hz. A capillary of tetra- 
methylsilane (TMS) in carbon tetrachloride was used as an external 
reference and the position of all peaks was reported relative to this 
compound.
b) 19F and 31P NMR
50 mg/ml of EPC or dipalmitoyl lecithin (L-a-dipalmitoylphosphatidyl- 
choline; henceforth referred to as DPL) was sonicated in a glucose free, 
modified Ringer buffer (121 mM NaCl, 5.4 mM KC1, 1.2 mM MgS04, 1.2 mM 
NaH2P04, 15 mM NaHC03, 2.5 mM CaCl2; pH 7.1-7.2). Sonication conditions were 
as described for NMR samples with the exception that cooling was not 
employed during sonication of the DPL samples. Spectra were obtained on 
a JOEL FX-90Q, fourier transform spectrometer operating at 36.2 MHz for 
31P and 84.26 MHz for 19F. The magnet was tuned to optimise field 
homogeneity using a deuterated solvent and the instrument was then switched
to external lock, thus avoiding the requirement for deuterated solvents 
in the test sample. Chemical shift data were reported relative to the 
usual standards of 85% orthophosphoric acid and 100% trifluoroacetic acid 
(TFA) for 31P and 19F nuclei, respectively; however the primary external 
references used were 1M methylene diphosphonic acid (MDP) in D2°> PH = 9-° 
(31P) and 5% TFA in H20 (19F). All 31P and 19F spectra were recorded 
at 30°C.
4.2.2 Materials
TFA and TMS were obtained from Aldrich Chemical Company. MDP 
was from Sigma Chemical Company and orthophosphoric acid from British Drug 
Houses. D20 (99.7%) was obtained from the Australian Atomic Energy 
Commission.
4.3 RESULTS
4.3.1 *H NMR spectra of lecithin and lecithin-cholesterol membranes 
The type of information available from 3H NMR spectroscopy is 
simply shown in Figure 4.1, where the resonance signals arising from the 
choline, methylene and terminal methyl protons give an almost complete 
picture of the lipid environments within a model phospholipid membrane.
The method of preparation and the presence of cholesterol had dramatic 
effects on the resonance signals from these 3 groups (Figure 4.2).
The co-sonication of cholesterol (12.5 mg/ml) with EPC (50 mg/ml) almost 
abolished the methylene and methyl proton signals and reduced the choline 
signal by a factor of 3 (Figure 4.2A compared to Figure 4.3C). There was 
no discernible resonance peaks in the vortexed EPC samples (Figure 4.2B). 
The sonicated EPC spectrum shown in Figure 4.2C is similar to that used 
in Figure 4.1 and is included for comparative purposes.
Figure 4.1: *H NMR spectrum of sonicated EPC vesicles
This schematically illustrates the regions of the EPC molecule which
contribute to the spectrum. Chemical shifts were referenced against TMS.
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Figure 4.2: Effect of cholesterol and method of preparation on the *H
NMR spectrum of EPC
(A) Sonicated EPC-cholesterol vesicles (50 and 12.5 mg/ml) respectively.
(B) Vortexed EPC multi bilayers (50 mg/ml).
(C) Sonicated EPC vesicles (50 mg/ml).
Chemical shifts were referenced against TMS.
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The addition of halothane (up to 94.7 mM) had little effect on 
*H resonance signals in vortexed EPC samples or in sonicated EPC and EPC- 
cholesterol lipid samples (results not shown). Greater volumes of 
halothane (up to 0.47 M) increased the choline, methylene and methyl 
resonances in vortexed EPC and EPC- cholesterol samples, but actually 
decreased choline and methylene resonances in sonicated EPC lipid samples 
(results not shown).
4.3.2 *H NMR spectra of normal and MU microsomal membranes and lipid 
extracts
*H spectra were obtained of the light and heavy microsomal trapezius 
fractions and of the heavy microsomal 1. dorsi fraction and of their lipid 
extracts, from both normal and MH muscles. Figure 4.3 shows spectra 
obtained of a MH trapezius light microsomal fraction (A) and its equivalent 
lipid extract (B). The addition of halothane (up to 94.7 mM) resulted in 
an increase in the intensity of the methylene resonances in both the 
membrane and lipid extract samples. Similar spectra were obtained for the 
other normal and MH muscle fractions and in all cases the effects of 
halothane failed to distinguish normal from MH fractions.
The effects of temperature were monitored in the light and heavy 
microsomal membrane fractions from normal and MH trapezius muscle. 
Temperature effects, in the 10°C to 70°C range, are shown in Figure 4.4 
for a normal trapezius light microsomal fraction. The small increase in 
width of the methylene resonance is indicative of an increase in the number 
of nuclei contributing to the signal. Temperatures in the 10°C to 70°C 
range had only small effects on *H resonances and such behaviour was 
characteristic of both normal and MH muscle fractions.
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Figure 4.3: Effect of halothane on the *H NMR spectra of MH trapezius
light microsomal membrane and sonicated lipid extract
(A) Light microsomal membrane. (B) Light microsomal membrane lipid extract.
Bars indicate methylene peak height. Similar spectra were obtained for
other normal and MH membrane and lipid extract preparations. Chemical
shifts were referenced against TMS.
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Figure 4.4: Effect of temperature on the *H NMR spectrum of normal
trapezius fight microsomal membranes
Samples were equilibrated at the appropriate temperature for 10 minutes
prior to obtaining a spectrum. Similar spectra were obtained for other
normal and MH membrane and lipid extract preparations. Chemical shifts
were referenced against TMS.
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Figure 4.5: 31P NMR spectrum of sonicated EPC vesicles
Typical 31P spectrum of sonicated EPC (50 mg/ml) vesicle preparation. 
Chemical shifts were reported relative to 85% orthophosphoric acid. 
31P assignments were according to Berdon et al, 1975.
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Figure 4.6: Effect of halothane on the 31P NMR spectrum of sonicated EPC
and PPL vesicle preparations
(A) EPC (no additions); (B) EPC (47.4 mM halothane);
(C) DPL (no additions); (D) dpl (47.4 mM halothane).
Samples contained 50 mg/ml lipid. Chemical shifts (ppm) were referenced 
against 85% orthophosphoric acid.
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Figure 4.7: Effect of environment on chemical shift positions of the
19F nucleus of halothane
The external references (A) and (G) were 5 and 100% TFA, respectively. 
Halothane (47.4 mM) was added to the various samples (B, C, D and F) and 
the 19F spectra recorded 10 minutes later. Chemical shifts were referenced 
against 100% TFA (G). The structure of halothane is shown at the top of 
the figure.
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4.3.3 31P NMR studies of halothane-phospholipid interactions
The 31P NMR spectrum of a sonicated EPC preparation is shown in 
Figure 4.5. The orthophosphate resonance (not shown) appears quite close 
to the phospholipid resonances and for this reason MDP was used as the 
primary reference (Figure 4.5). The environments in the outer (EPC out) 
and inner (EPC in) regions of EPC vesicles differ as evidenced by the 
different shift positions for the EPC phosphorus at either side of the 
vesicle (Figure 4.5). The separation between the outside and inside 
resonances was 5.2 Hz and the EPC out/EPC in ratio was 1.6 (Figure 4.5).
Figure 4.6 shows the 31P spectra of sonicated EPC and DPL 
vesicles in the absence and presence of 47.4 mM halothane. The spectrum 
of the sonicated EPC vesicles (Figure 4.6A) is similar to that shown in 
Figure 4.5. The addition of halothane had no effect on the splitting 
between the resonances but the EPC out/EPC in ratio increased from 1.60 
(Figure 4.6A) to 1.80 (Figure 4.6B). In the absence of halothane outside 
and inside DPL resonances were broad with a splitting of 6.4 Hz and a DPL 
out/DPL in ratio of 1.45 (Figure 4.6C). Halothane (47.4 mM) sharpened 
both the outside and inside resonances of DPL vesicles, decreased the 
splitting between resonances to 5.1 Hz and decreased the DPL out/DPL in 
ratio to 1.3 (Figure 4.6D).
4.3.4 19F NMR studies of halothane-phospholipid interactions
The 19F spectrum of the fluorine on halothane is a doublet peak 
(Figure 4.7) caused by the interaction of the fluorine nuclear spin with 
that of the proton on the adjacent carbon. The sensitivity of halothane 
to its environments is simply shown in Figure 4.7 where the shift positions 
of the halothane doublet are shown in a number of different solvents. The 
halothane resonances shown in Figure 4.7 (i.e. traces B, C, D, E and F)
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represent results of individual experiments but were included on the same 
figure to illustrate how solvent environment affects fluorine chemical 
shifts. Thus using 100% TFA (G) as reference, the doublet centre was 
upfield of the reference, at 0.95 ppm in hexane (F), at 1.29 ppm in 
concentrated halothane (E), at 2.73 ppm in a DPL vesicle suspension (D), 
at 2.72 ppm in an EPC vesicle suspension (C) and at 2.87 ppm in Ringer 
buffer (B) (Figure 4.7).
The 19F spectra of halothane in EPC (Figure 4.7C) and DPL 
(Figure 4.7D) vesicles were recorded on the same samples used for the 31P 
spectra shown in Figure 4.6B and D, respectively. The 19F spectra show 
(Figure 4.7) that the partitioning of halothane into increasingly 
hydrophilic or polar solvents results in a progressive upfield shift of 
the halothane from the 100% TFA reference (Figure 4.7). The appearance 
of a single doublet in the 19F spectra of halothane in EPC and DPL 
vesicles, intermediate between Ringer and hexane, implies that the 
halothane in the lipid vesicles rapidly exchanges between the lipid and 
aqueous phases and that the amount of halothane permanently bound within 
the vesicle is small.
4.4 DISCUSSION
The spectra of EPC membranes demonstrate how structural 
composition and organisation affect individual proton resonances. 
Sonication of EPC resulted in the formation of vesicles with well 
resolved choline, methylene and methyl resonances, while vortexed samples 
were characterised by the absence of resolved resonances. The 
co-sonication of cholesterol and EPC resulted in the formation of vesicles 
which were characterised by a marked decrease in the choline resonance 
while the methylene and methyl resonances were almost abolished. These
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observations are consistent with EPC forming small, highly curved 
vesicles when sonicated and large multi-bilayer structures when vortexed 
(Sheetz and Chan, 1972; Chan et at., 1973). The absence of methylene and 
methyl resonances in EPC-cholesterol vesicles indicates that the molecular 
mobility (on the NMR time scale) of the fatty acyl side chains of the 
phospholipid is restricted in the presence of cholesterol. Such an 
interpretation is consistent with currently held views on the function of 
cholesterol in model and biological membranes (Drake et at. , 1972; Demel 
and De Kruyff, 1976; Papaladjopoulos, 1976). These simple experiments 
using NMR spectroscopy show how structure and composition affect the 
*H spectrum. This provided a useful basis upon which subsequent NMR 
studies of halothane-muscle membrane interactions were carried out.
High resolution l\\ NMR spectra have been obtained for a number 
of biological membrane preparations, including SR membranes (Davis and 
Inesi, 1971; Eletr and Inesi, 1972; Davis and Inesi, 1972; Robinson 
et at, , 1972; Davis et at. , 1976; Vanderkool et at., 1977), erythrocyte 
membranes (Chapman et at. , 1968), retinal rod outer segment disc membranes 
(Brown et at. , 1977) and yeast and rat liver mitochondrial membranes 
(Brown et at. , 1975) These *H spectra were remarkably similar, with the 
predominant signals arising from the choline, methylene and methyl protons 
of the phospholipids (Davis et at., 1976; Brown et at., 1975; Brown et at., 
1977). This indicates that the molecular environments of these phospholipid 
functional groups are similar and that structural organisation in biological 
membranes displays features common to all membrane systems. Lipid mobility 
at the molecular level comprises the rotational motion about the bonds of 
the fatty acid side chains and the translational motion of the lipid 
molecule within the plane of the membrane (Marsh, 1975). Thus the 
spectrum provides qualitative information on the physical state of the
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membrane with the resonance intensity (i.e. the percentage of the total 
resonances contributiong to the signal) reflecting the "fluid" state of 
the membrane. Elevations in temperature (Davis et at., 1976) or the 
addition of halothane (Vanderkooi et at., 1977) intensified methylene, 
methyl and, to a lesser extent, choline resonances in SR membrane 
preparations, indicating that such treatments have a common mode of action. 
The fluidising effects of halothane on SR membranes reported by Vanderkooi 
et at. (1977) agree with the effects of halothane on normal and MH microsomal 
preparations observed in the present study.
The absence of a choline resonance in the membrane and sonicated 
lipid preparations studied here, contrasts with its predominance in *H 
spectra of SR membranes (Davis and Inesi, 1971; Eletr and Inesi, 1972;
Davis and Inesi, 1972; Davis et at., 1976) and of sonicated SR lipid 
extracts (Robinson et at. , 1972). Possible explanations for this include 
a specific interaction between the choline head group and membrane 
proteins, resulting in significant line broadening, or that the -^H spectrum 
reflects not only phospholipid resonances but also mono-, di- and 
triglyceride and free fatty acid resonances. The absence of a choline 
resonance has been proposed to reflect membrane integrity (McLaughlin 
et at. , 1977) and as sonication was not employed in the preparation of the 
microsomal membranes, head group immobilisation by membrane proteins cannot 
be ruled out. In the sonicated microsomal lipid extracts the absence of 
a choline resonance (over all the conditions studied) indicates that in 
these preparations other possibilities must be considered. Non-steroidal 
neutral lipids (i.e. mono-, di-, and triglycerides and free fatty acids) 
constitute a major percentage of the total lipid (up to 40%; J. Sullivan 
and M.A. Denborough, unpublished results) in muscle microsomal membrane 
preparations. Therefore, their contribution might explain the predominance
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of methylene and methyl resonances and a complete absence of choline 
resonances in the *H spectra of microsomal membrane preparations. Neutral 
lipids occur in most biological membranes and although many studies have 
documented structural and functional roles for cholesterol, similar studies 
have not been carried out on non-steroidal neutral lipids. The numerous 
centrifugation steps employed during the fractionation procedure, rule out 
the possibility that such lipids were contaminants but in the absence of 
a defined role for non-steroidal lipids in biological membranes the 
significance of their contribution to the Hi NMR spectrum remains to be 
clarified.
Temperature-induced enhancement of methyl, methylene and choline 
resonances characterise *H spectra of model (Sheetz and Chan, 1972) and 
biological membranes (Brown et al. , 1975; Davis et al. , 1976; Brown 
et al. , 1977). Elevations in temperature enhanced methyl and methylene 
resonances in both normal and MH microsomal membrane and lipid preparations 
and responses failed to differentiate the two muscle types. The resonance 
enhancement was small but was indicative of an increase in the pool size 
of "melted" lipids. Such small effects of temperature may in part reflect 
the immobilising presence of cholesterol or that the resonances arise from 
non-phospholipid molecules (i.e. the non-steroidal neutral lipids discussed 
earlier). These possibilities require further study.
The inability to differentiate normal from MH muscle preparations 
on the basis of Hi NMR spectroscopy, indicates that the molecular 
environments surrounding the contributing resonances are similar. This 
indicates that the abnormality underlying MH is subtle and is probably 
localised at the direct level of protein structure and/or function, although 
an indirect effect on the stability of lipid-protein interactions cannot be 
ruled out. The Hi spectra indicate that a gross alteration in the structure
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of MH muscle microsomal membranes is unlikely but this may reflect the 
heterogeneous nature of the membranes included in the microsomal preparations. 
Further work using purer membrane fractions would be required to assess 
such a possiblity.
31P NMR of sonicated EPC vesicles permitted the simultaneous 
monitoring of PC moieties on each side of the membrane bilayer. The EPC 
outside/inside ratio of 1.6 to 1.8 agreed with previously published values 
for the outside/inside distribution of EPC and a variety of other 
unsaturated PCs in vesicle preparations (Berdon et at., 1975; De Kruijff 
et at. , 1976). The predominance of unsaturated fatty acids in the EPC 
used in the current study (unsaturated/saturated ratio 1.4) ensured that 
at 30°C the EPC was in a fluid state. The phase transition or the melting 
temperature of DPL is 41°C and therefore at 30°C this lipid is in a solid 
state. The 31P spectra reflected this physical state of the membrane with 
the fluid EPC vesicles displaying well resolved outside/inside resonances 
while the solid DPL vesicles displayed a broader, less resolved splitting 
of outside and inside resonances. The addition of 47.4 mM halothane to 
sonicated EPC vesicles had little effect on the 31P spectrum. This was 
not unexpected as halothane was added to an already fluid membrane.
Sonicated DPL vesicles by contrast displayed a sharpening of the outside/ 
inside resonances and greater resolution of the splitting between these 
resonances when 47.4 mM halothane was added. This effect of halothane on 
the 31P spectrum of sonicated DPL vesicles was similar to that observed 
when the spectrum was obtained at 50°C in the absence of halothane 
(Berdon et at. , 1974).
1<3F NMR was employed to monitor halothane environments in the same 
EPC and DPL vesicle preparations from which 31P spectra were obtained. In
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agreement with previous reports (Trudell and Hubbell, 1976; Koehler et at., 
1977a, b) the halothane chemical shift positions reflect the environment 
surrounding the halothane molecule. Direct comparisons between the 
chemical shift positions of the halothane doublet and the environmental 
factors contributing to these shifts were possible only with Trudell and 
Hubbell*s (1976) study where shift positions were referenced against 100% 
TFA. The use of hexafluoroacetone by Koehler et at. (1977a, b) as an 
external fluorine reference meant that chemical shift comparisons between 
their results and the results obtained in the present study could not be 
carried out. Trudell and Hubbell (1976) obtained centered chemical shifts 
of 2.79, 2.57 and 0.99 ppm upfield of 100% TFA when halothane was 
dissolved in water, sonicated EPC vesicles or hexane repsectively. The 
comparable values obtained in the present study of 2.87, 2.72 and 0.95 ppm 
for halothane in Ringer, sonicated EPC vesicles and hexane, respectively 
are in good agreement with Trudell and Hubbell*s (1976) results. The 
similar shift positions for halothane in sonicated EPC (2.72 ppm) and DPL 
(2.73 ppm) vesicles, indicates that in these preparations, halothane 
environments are similar. The difference in peak height might reflect 
the lower partitioning of halothane into DPL vesicles at 30°C (i.e. below 
its phase transition temperature) compared to its partitioning into EPC 
vesicles at the same temperature. Indeed it has been shown that at 25°C 
halothane partitioning into EPC vesicles is four-fold higher than that into 
DPL vesicles (Simon et al., 1979).
The use of 19F and 31P NMR to study halothane-phospholipid 
interactions provides a simple means with which to monitor halothane and 
phospholipid environments in the same sample. The application of such an 
approach to study MH muscle membranes could provide important information 
as to the nature of the interaction between halothane and MH muscle
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membranes. Such an approach remains for future investigations.
4.5 SUMMARY
NMR techniques are well suited to provide structural and dynamic 
information in a non-perturbing manner on model and biological membranes.
In this study a number of aspects of membrane structure and function have 
been investigated using 19F and 31P NMR spectroscopy. In normal and 
MH microsomal muscle membranes and their lipid extracts elevations in 
temperatures or the addition of halothane enhanced methylene and methyl 
resonances in the Ml spectrum, but such effects were similar in normal and 
MH preparations. Choline resonances were absent in all muscle preparations 
studied. The molecular environments of sonicated EPC and DPL vesicles 
differed as evidenced by the 31P NMR spectrum, the EPC spectrum being well 
resolved into signals from each side of the bilayer while the DPL spectrum 
was broad and outside/inside resonances were less well resolved.
Halothane interactions with these vesicle systems were studied using 19F NMR 
and it was shown that halothane environments were similar in sonicated EPC 
and DPL vesicles, although the amount bound by the former preparation was
greater.
CHAPTER 5
TEMPERATURE DEPENDENCE OF SKELETAL MUSCLE FUNCTION 
IN PORCINE MALIGNANT HYPERPYREXIA
5.1 INTRODUCTION
Contractile hypersensitivity in human MH skeletal muscle to the 
calcium releasing drug caffeine was first demonstrated in 1970 by Kalow 
and co-workers in Toronto. On the basis of this finding, it was 
concluded that in MH there is a disturbance in intracellular calcium 
metabolism in skeletal muscle (Kalow et at. , 1970). These experiments 
were carried out at 25°C, and at this temperature halothane failed to 
induce a contracture in MH muscle. Subsequent work has shown that 
halothane-induced contractures are an in vitro pharmacological feature of 
MH muscle (Ellis et at. , 1972; Moulds and Denborough, 1972), but that 
their occurrence is temperature dependent (Nelson et al. , 1975). Caffeine 
contractures are temperature dependent in mammalian skeletal muscle with 
contractile sensitivity being greater at 37°C than at room temperature 
in human (Nelson et at., 1977) and in rat (Frank and Buss, 1967) skeletal 
muscle. The temperature dependence of caffeine-induced contractures has 
not previously been investigated in MH skeletal muscle. In rat skeletal 
muscle contractures in response to the isotonic replacement of NaCl with 
KC1 are greater at 37°C than at 22°C (Frank and Buss, 1967). 
Succinylcholine, KC1 and changes in temperature are some of the additional 
diverse stimuli which induce an abnormal contracture in MH skeletal 
muscle (Moulds and Denborough, 1974), but a systematic investigation of 
the temperature dependence of these processes has not previously been 
attempted.
91
In the 20° to 40°C temperature range isometric twitch behaviour 
in rat (Close and Hoh, 1968; Hanson, 1974; Ranatuanga, 1977a), and 
cat (Ranatuanga, 1977b) skeletal muscle is dependent on muscle fibre 
type. Over this temperature range the pattern of isometric twitch changes 
little in red muscles, while in white muscle cooling significantly 
increases the size of the twitch response (Close and Hoh, 1968;
Ranatuanga, 1977a, b). Thus isometric twitch of mammalian muscles as a 
function of temperature can be used as an indicator of the predominant 
fibre type which characterises any individual muscle.
The objectives of the experiments described in this chapter were;
(1) to examine the effects of temperature on isometric twitch 
and contracture in response to halothane, caffeine, 
succinylcholine, and KC1 in normal and MH porcine skeletal 
muscle, and
(2) to determine the optimum temperature at which the in vitro 
pharmacological assessment of MH susceptibility should be 
carried out.
5.2 MATERIALS AND METHODS 
5.2.1 Methods
Premedication and nitrous oxide-barbiturate anaesthesia were 
carried out as described in section 3.2.1. A total of 14 MH and 3 normal 
swine were biopsied. In all cases susceptibility was assessed by 
standardised pharmacological methods (Okumura et al. , 1979). Clamped 
biopsy samples of approximate dimensions 4 cm by 1 cm by 0.3 cm, length, 
width and depth respectively were removed from the gracilis muscle and 
placed in a modified Ringer buffer (121 mM NaCl, 5.4 mM KC1, 1.2 mM MgS04,
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1.2 mM NaH2P04, 15 mM NaHC03, 11.5 mM d-glucose, 2.5 mM CaCl2; pH 7.4) 
at 37°C, which was continuously bubbled with carbogen (95% 02/5% C02).
From 3 to 5 clamps were taken from each animal. Prior to use a fibre 
bundle (approximately 100 mg wet weight) was cut from the bulk muscle and 
tied off at either end to small (0.3 cm diameter) metal rings using 
Ethicon size '00' silk thread. One end of the fibre bundle was fixed to 
a glass rod, and the other to a force transducer (Watson Victor), and the 
muscle preparation was lowered into a jacketed organ bath containing 
25 ml of modified Ringer buffer. Isometric tension was recorded after 
amplification (San-Ei 6M52 strain amplifier); the resting tension was 
1 gram. Twitch responses were obtained with DC square waves generated 
by a Grass Model S4E stimulator, via platinum electrodes, to the following 
specifications; 3 msec duration, 30 V and a frequency of 0.1 Hz. This level 
of stimulation constituted supra maximal twitch at 25°C and 37°C.
Temperature control was maintained with a Braun thermomix, 
equipped with a mercury contact thermometer. For fixed temperature 
experiments in the 20° to 45°C range the circulating water bath temperature 
was set at the appropriate level and the muscle buffer temperature was 
permitted to equilibrate to the pre-set level prior to the transfer of 
the fibre bundles to the muscle bath. Utilising this procedure, buffer 
temperature was maintained to within ±0.5°C of the pre-set level. Lower 
temperatures were maintained by the addition of ice to the circulating 
water bath. This procedure maintained temperatures to within ±1.0°C of 
the pre-set level. In experiments designed to follow twitch and tension 
responses to a gradual rise in temperature both the circulating water bath 
and muscle buffer temperatures were separately monitored. Fibre bundles 
were first equilibrated at 5°C and the final temperature set at 37°C.
This resulted in a temperature rise in the buffer of approximately 2.5°C/min.
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Throughout the experiments the bulk muscle was maintained at 37°C in 
carbogen treated Ringer and the order in which the experiments were carried 
out was varied from day to day.
The stock solutions of the drugs used were: caffeine, 100 mM in
Ringer; potassium chloride, 4 M in Ringer; acetylcholine, 125 mM in 
distilled water; dantrolene sodium, 3 mM in dimethyl sulphoxide and 
tubocurarine 1.47 mM in distilled water. Halothane was administered by 
passing carbogen through a temperature calibrated Dragewick vaporizer. 
Physostigmine (0.5 pM) was added directly to the buffer. Calcium was 
omitted when preparing calcium free buffers and when required, 2 mM 
ethylene glycol-bis-(ß-aminoethylether)N,N'-tetraacetic acid (EGTA) was 
added to this calcium free Ringer. Deuterium oxide (D20) Ringer was 
prepared by dissolving the normal buffer salts in D20. No correction was 
made for pH in such solutions (note: pD = pH + 0.4 [Huxtable and Bressler, 
1974]). D20 purity was in excess of 99.7% and re-use after redistillation
did not modify its action. Glycerinated fibres were prepared by pre­
treatment of separated, tied, fibre bundles in Ringer supplemented with 
400 mM glycerol. This treatment was carried out at 37°C in carbogen 
treated buffer for one hour. pH corrections for the modified Ringer buffer 
at 5°C were calculated from the formula relating pH to temperature as used 
by Creese et at. (1958).
One fibre bundle per animal was used for each drug at any one 
temperature while up to 3 fibre preparations per animal were used in the 
twitch experiments. Significance values were obtained using the Student's 
t-test. In drug contracture experiments significance values, for MH 
muscle only, were expressed relative to the contracture induced at 37°C.
In twitch recovery experiments significance values for MH muscles were
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expressed relative to normal twitch at a similar temperature. Values 
expressed in Figures 5.2 to 5.6 are reported as means ± S.E.M.
5.2.2 Materials
The buffer salts, potassium chloride, glycerol, and acetylcholine 
chloride were obtained from British Drug Houses. Caffeine, physostigmine, 
and EGTA were from Sigma Chemical Company. Succinylcholine chloride 
(Scoline) and tubocurarine chloride (Tubarine) were obtained from Wellcome. 
Deuterium oxide was obtained from the Australian Atomic Energy Commission. 
Procaine hydrochloride was from David Bull Laboratories, and halothane from 
Imperial Chemical Industries. Dantrolene sodium was the kind gift of 
Dr K.O. Ellis, Norwich Eaton Pharmaceuticals.
5.3 RESULTS
5.3.1 Temperature effects on tension and twitch
Twitch recovery as a function of temperature was similar in normal 
(Figure 5.1) and MH muscle but in most cases recovery proceeded faster 
in the latter muscle (Figure 5.2). The temperature at which maximal 
twitch occurred (Figure 5.2) was significantly different (p < 0.05) in MH 
(21.2 ± 0.8°C, n = 12) and normal (24.1 ± 0.7°C, n = 7) muscle preparations. 
Additional differences in twitch recovery were noted at temperatures 
below 20°C (Figure 5.2) where recovery of fibre twitch occurred earlier 
in MH muscle preparations. A slight increase in muscle tension occurred 
on heating the fibre bundles from 5°C to 37°C but this was always less 
than 0.1 gram in both normal (Figure 5.1) and MH muscle preparations.
A further increase in temperature from 37°C to 45°C resulted in a small 
increase in tension in normal (0.21 ± 0.1 grams, n = 5) and MH 
(0.20 ± 0.05 grams, n = 9) fibre bundles which was not significantly
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Figure 5.1: Effect of temperature on isometric twitch in normal porcine
gracilis muscle
Fibre preparations were incubated at 5°C for 6 minutes and then the 
temperature was raised (2.5°C/minute) to 37°C. Similar profiles 
characterised MH fibres with the exception that twitch recovery and twitch 
maximum occurred earlier than in normal muscle.
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Figure 5.2: Effect of temperature on isometric twitch in normal
and MH porcine gracilis muscle
Conditions were as described in Figure 5.1. Values are expressed as % 
of the maximum twitch recorded. Each point represents the mean ± S.E.M. 
of 7 (open circles) and 12 (closed circles) individual fibre preparations 
from 3 normal and 5 MH swine, respectively.
* p < 0.05
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different. Twitch responses were not studied in the 37° to 40°C temperature 
range. The addition of d-tubocurarine (final concentration 0.06 mM) to 
the muscle bath prior to the initiation of a temperature run failed to 
alter the twitch recovery pattern in normal (n = 3) or MH (n = 3) muscle 
preparations.
5.3.2 Temperature dependence of halothane contractures
The temperature dependence of 3% halothane-induced contractures 
is shown in Figure 5.3 for normal and MH muscle preparations. Alterations 
in temperature from 20°C to 45°C had little effect on the ability of 
halothane to cause contractures in normal muscle and in this temperature 
range contractures were always less than 0.05 grams. In MH muscle 
halothane-induced contractures were minimal at 25°C (0.14 ± 0.06 grams, 
n = 8) and plateaued at 37°C (1.09 ± 0.17 grams, n = 14). Large 
contractures were induced at 5°C both in normal (1.45 ± 0.17 grams, n = 3) 
and MH (1.31 ± 0.27 grams, n = 8) muscle preparations (Figure 5.3).
5.3.3 Temperature dependence of caffeine contractures
Temperature effects on 2 mM caffeine contractures in normal and 
MH muscles (Figure 5.4) were qualitatively similar to those obtained with 
halothane (Figure 5.3). Normal muscle failed to contract to 2 mM caffeine 
in the 20°C to 45°C temperature range, while in MH muscle 2 mM caffeine 
contractures increased as the temperature was raised from 20°C (0.12 ± 0.04 
grams, n = 11) to 37°C (0.64 ± 0.11 grams, n = 14). Both normal and MH 
muscle displayed enhanced caffeine sensitivity at 5°C with contractures of 
1.52 ± 0.19 grams (n = 3) and 2.26 ± 0.60 grams (n = 7) for normal and MH 
muscles, respectively (Figure 5.4).
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5.3.4 Temperature dependence of succinylcholine contractures
Contractures induced by 1 mM succinylcholine displayed a similar 
qualitative contractile dependence on temperature (Figure 5.5) as 
halothane (Figure 5.3) and caffeine (Figure 5.4). In MH muscle 
succinylcholine induced small contractures in the 20°C to 30°C temperature 
range and these increased to a maximum at 45°C (0.56 ± 0.16 grams, n = 7). 
Normal muscle failed to contract in this temperature range. Large 
contractures were induced at 5°C in normal (1.45 ± 0.17 grams, n = 3) and 
MH (1.3 ± 0.27 grams, n = 8) muscle (Figure 5.5).
5.3.5 Temperature dependence of KC1 contractures
80 mM KCl-induced contractures displayed a qualitatively and 
quantitatively distinct temperature dependence pattern (Figure 5.6) 
compared with halothane (Figure 5.3), caffeine (Figure 5.4) and succinyl­
choline (Figure 5.5). Between 5°C and 45°C KC1 had little effect on muscle 
tension (<0.1 grams) in normal muscle preparations. In MH muscle KC1 had 
little effect on tension at 5°C, 20°C or 25°C (<0.1 grams). The maximum 
contracture recorded in MH muscle in response to KC1 occurred at 37°C 
(1.77 ± 0.33 grams, n = 14) (Figure 5.6).
5.3.6 Drug induced contractures at 5°C
As mentioned above 3% halothane (Figure 5.3), 2 mM caffeine 
(Figure 5.4) and 1 mM succinylcholine (Figure 5.5) induced large contractures 
in both normal and MH muscle fibres at 5°C. 80 mM KC1 had no effect on
muscle tension in either normal or MH muscle at 5°C (Figure 5.6).
Repeated drug treatments in a calcium free buffer at 5°C, resulted 
in a progressive decrease in the extent of the contracture in normal and 
MH muscle preparations. This was true for halothane, caffeine and
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Figure 5.3: Temperature dependence of 3% halothane-induced contractures
in normal and MH porcine gracilis muscle
Fibre bundles were equilibrated at the appropriate temperature for a
minimum of 5 minutes prior to the addition of halothane. Each point
represents the mean ± S.E.M. of 3 normal (open circles) and 7-14 MH (closed
circles) separate fibre preparations. Significance values are relative
to the contracture induced at 37°C and apply to MH preparations only.
** p < 0.01 
*** p < 0.001
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Figure 5.4: Temperature dependence of 2 mM caffeine-induced contractures
in normal and MH porcine gracilis muscle
Fibre bundles were treated as described in Figure 5.3. Each point represents
the mean ± S.E.M. of 3 normal (open cirlces) and 7-14 MH (closed circles)
separate fibre preparations. Significance values are referenced against
the contracture induced at 37°C and apply to MH preparations only.
** p < 0.01 
*** p < 0.001
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Figure 5.5: Temperature dependence of 1 mM succinylcholine-induced
contractures in normal and MH porcine gracilis muscle
Fibre bundles were treated as described in Figure 5.3. Each point
represents the mean±S.E.M. of 3 normal (open circles) and 7-14 (closed
circles) separate fibre preparations. Significance values are referenced
against the contracture induced at 37°C and apply to MH preparations only. 
* *
* * *
p < 0.01 
p < 0.001
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Figure 5.6: Temperature dependence of 80 mM KC1-induced contractures
in normal and MH porcine gracilis muscle
Fibre bundles were treated as described in Figure 5.3. Each point
represents the mean ±S.E.M, of 3normal(open circles) and 7-14 MH (closed
circles) separate fibre preparations. Significance values are referenced
against the contracture induced at 37°C and apply to MH preparations only.
* p < 0.05
** p < 0.01 
*** p < 0.001
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succinylcholine (n = 2, for each drug in normal and MH muscle preparations). 
Prior treatment with 2 mM EGTA at 37°C for one hour abolished 2 mM caffeine 
and 3% halothane contractures in both normal and MH muscle in a calcium 
free buffer at 5°C (single experiments only).
Acetylcholine (1 mM) in the presence of the choline-esterase 
inhibitor physostigmine (0.5 yM), did not induce a contracture in normal 
(n = 2) or MH (n = 2) fibre bundles at 5°C. Glycerol-induced T-tubular 
disruption failed to alter the time course or the extent of contracture 
to halothane, caffeine or succinylcholine in MH muscle (n = 2 for each 
drug) at 5°C. Replacing the normal modified Ringer buffer with D2O Ringer 
buffer did not affect halothane- or caffeine-induced contractures in MH 
muscle (n = 2, for each drug). Dantrolene sodium (12 yM) did not block 
halothane- or caffeine-induced contractures at 5°C in normal or MH muscle 
preparations (single experiments only).
The modified Ringer buffer used in these studies gave a pH of 
6.9 at 5°C, but correcting this (by the addition of NaHCC^) to give 
a pH of 7.4 at 5°C did not affect the halothane- or caffeine-induced 
contractures in MH muscle preparations (n = 2 for each drug).
In MH muscle at 5°C 10 mM procaine blocked halothane contractures 
by over 50% (n = 2), and 5 mM procaine blocked caffeine contractures by 
up to 70% (n = 2).
5.4 DISCUSSION
The isometric twitch behaviour of gracilis muscle from normal and 
MH swine in the 20°C to 40°C temperature range is qualitatively characteristic 
of mammalian fast twitch white fibres (Turang et at., 1964; Close
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and Hoh, 1968; Hoh, 1974). Histochemical studies (K. Hopkinson and 
M.A. Denborough, unpublished results) show that porcine gracilis muscle 
is a fast twitch white muscle.
The inability of the acetylcholine antagonist d-tubocurarine to 
modify either the recovery or the pattern of twitch as a function of 
temperature, argues against the involvement of acetylcholine release and 
the MEP as possible contributory agents responsible for the temperature- 
twitch profile displayed by porcine gracilis muscle.
The increase in twitch displayed by swine gracilis muscle 
(Figures 5.2 and 5.2) on decreasing temperature from 37°C to 20°C, 
contrasts with the decreased contractile responses to halothane, caffeine, 
succinylcholine and KC1 over the same temperature range. A similar 
situation has been described in rat extensor digitorum longus muscle 
where twitch (Close and Hoh, 1968) and caffeine contractures (Frank and 
Buss, 1967) increase and decrease, respectively as temperatures are 
lowered. As the final events in contraction are common to both twitch 
and drug-induced contraction (i.e. calcium release and myofibrillar 
interdigitation), an explanation for their different temperature 
sensitivities may reside in the sequence of events occurring prior to 
calcium release. Thus it is proposed that in MH muscle the initial 
events of E-C coupling, as induced by electrical stimulation and by the 
drugs tested here, differ.
It is possible that the hypersensitive drug-induced contractures, 
which are observed in MH muscle at 37°C may reflect the ability of such 
drugs such as halothane, caffeine and succinylcholine to initiate a 
calcium-induced calcium release process (Endo, 1977; Ebashi, 1979) which 
does not occur in normal muscle. Such a drug-induced release of trigger 
calcium does not presumably occur at 20°C or 25°C where this calcium pool
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is effectively immobilised. The occurrence and relative importance of 
calcium-induced calcium release in pathological muscle needs further 
investigation.
Biochemical studies in isolated rat (Becker and Willis, 1975) and 
porcine (McIntosh et at. , 1977) SR preparations have shown that Ca ATPase 
activity decreases as temperatures are lowered from 37°C to 20°C. Thus 
a decrease in caclium uptake may underlie the greater twitch recorded in 
normal and MH muscles in the 20°C to 25°C temperature range, but this 
effect cannot explain the loss of drug induced contractility that occurs 
over the same temperature range in MH muscle. It is thus possible that 
the primary abnormality in MH resides in the processes modulating the 
release of activator calcium although our limited knowledge about such 
processes even in normal muscle (Adrian, 1979; Caputo, 1979) restricts 
detailing such an abnormality.
The decreased drug-induced contractility displayed by MH muscle 
on reducing temperature from 37°C to 25°C suggests that the hypersensitive 
step(s) coupling excitation to subsequent calcium release has been 
dissociated and it is proposed that this site is localised at the level 
of the functional interaction between the T-tubule and the sarcoplasmic 
reticulum.
Calcium uptake by rabbit SR fragments is abolished at 2°C 
(Martonosi and Feretox, 1964) thus suggesting that the large drug 
contractures induced at 5°C may reflect a decrease in the ability of 
porcine SR to accumulate calcium. The calcium dependence of the 5°C 
drug contractures was illustrated by their abolition after treatment 
at 37°C with calcium-free EGTA buffer, and by their diminution with 
repeated drug treatments in calcium-free Ringer. The disappearance of
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twitch and the loss of KCl-induced contractures at 5°C imply a loss of 
surface excitability, and it is possible that halothane, caffeine and 
succinylcholine induce muscle contraction at 5°C by a direct action on 
sarcoplasmic reticular stores of calcium. The similarity between the 
extent of contracture induced by these drugs at 5°C in normal and MH 
muscle indicates that under these conditions the amount of calcium 
released does not differ between the two muscle preparations.
The local anaesthetic procaine was the only drug tested which had 
any inhibitory effect on these low temperature contractures. Membrane 
stabilisation or a more direct antagonism of intracellular calcium release 
are two proposed mechanisms by which procaine antagonises drug-induced 
contractures in skeletal muscle (Moulds, 1974) and either mechanism is 
compatible with the results reported here.
Contractures in response to 3% halothane, 2 mM caffeine or 1 mM 
succinylcholine at 5°C were not modified by;
(1) pretreatment with dantrolene sodium (12 yM)
(2) replacement of the normal modified Ringer buffer with a 
D2O Ringer buffer
(3) glycerol-induced T-tubular disruption.
The latter three treatments have been used to study the role of 
abnormal E-C coupling in MH muscle at 37°C (Okumura et al., 1980). The 
inability of these E-C uncoupling treatments to modify halothane-, caffeine- 
or succinylcholine-induced contractures at 5°C suggests that surface 
membrane excitability is not a requirement for such low temperature 
contractures and is further evidence for a direct action of these drugs
on the SR to induce calcium release.
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Alterations in buffer pH as a function of temperature have been 
noted for Hepes (Dahl and Henquin, 1978) and Ringer (Creese et al. , 1958) 
buffers. Bicarbonate based Ringer buffers display a complicated pH 
temperature relationship (Creese et al. , 1958) but in general pH decreases 
with decreasing temperature. Correcting the buffer pH to 7.4 at 5°C had 
little effect on halothane or caffeine contractures, indicating that the 
decrease in pH which occurred in the modified Ringer at 5°C had no effect 
on drug-induced contractures.
The rapid cooling contracture (RCC) which occurs in frog muscle 
(Conway and Sakai, 1960) in response to caffeine, at concentrations which 
constitute sub-threshold contractile doses at room temperature, bears some 
resemblance to the low temperature contractures studied in this 
investigation. An important difference resides in the temperature 
procedures used, as the caffeine RCC technique involves the rapid transfer 
of muscle from a 20°C buffer to one maintained at 0°C (Conway and Sakai, 
1960) while the fixed temperature method employed in the present study 
allows equilibration at 5°C prior to the addition of any drug. An 
additional difference resides in the reported ability of dantrolene to 
inhibit caffeine RCC in frog muscle (Homma et al., 1976) compared with 
the inability of dantrolene to block halothane or caffeine-induced 
contractures in porcine muscle at 5°C.
The optimum temperature at which to assess MH susceptibility by 
in vitro pharmacological methods has been suggested to be 37°C (Denborough, 
1979). A similar conclusion had been reached by Nelson and co-workers on 
the basis of their observations on the temperature dependence of halothane- 
induced contractures in porcine MH muscle (Nelson et al. , 1975) and of 
caffeine-induced contractures in normal human muscle (Nelson et al. , 1977).
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In this study a detailed assessment of in vitro drug-induced contractures 
in porcine MH muscle, and to a lesser extent normal porcine muscle, over 
a range of temperatures indicates that the in vitro pharmacological 
assessment of MH susceptibility should be carried out at 37°C.
5.5 SUMMARY
The temperature dependence of twitch in normal and in MH swine 
gracilis muscle is characteristic of mammalian fast twitch, white fibres. 
Drug induced contractures are temperature dependent with normal and MH 
muscle preparations displaying unique temperature response profiles.
In MH muscle, halothane, caffeine and succinylcholine induced maximum 
contractures at 5°C which were not inhibited by dantrolene, D2O or 
glycerination. Increasing the temperature from 20° to 45° enhanced the 
contractile effectiveness of halothane, caffeine, succinylcholine and KC1 
in MH muscle. The hypersensitive E-C coupling that occurs in MH muscle 
at 37°C is abolished at 25°C and it is proposed that the site of this 
abnormal coupling is localised at the level of the triad. It is 
recommended that the in vitro assessment of MH susceptibility should be 
carried out at 37°C.
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CHAPTER 6
EFFECTS OF TMB-8 ON NORMAL AND MALIGNANT HYPERPYREXIC 
PORCINE SKELETAL MUSCLE
6.1 INTRODUCTION
The role of calcium ions in the physiological activation of
skeletal muscle contractile proteins is now firmly established
Sandow, 1965; Ebashi and Endo, 1968). Skeletal muscle is characterised
- 7by a low resting level of calcium (i.e. <10 M) in the myoplasm which 
increases rapidly prior to and during the development of a contracture 
(Sandow, 1970; Endo, 1977). Drugs which antagonise calcium release 
have been widely used in studies designed to assess the role of calcium 
in skeletal muscle function (Andersson, 1978). Such antagonists may act 
at a number of levels, but the end experimental result (i.e. antagonism 
of contractile responses) is a consequence of the maintenance of low 
intracellular calcium levels. In skeletal muscle calcium fluxes are 
primarily intracellular (Ebashi and Endo, 1968), although the qualitative 
and quantitative contribution of an influx of extracellular calcium 
remains to be clarified (Moulds and Denborough, 1974b; Barrett and Barrett, 
1978; Spiecker et al. , 1979). Calcium antagonists may be classified 
according to their site of action with extracellular influx and intra­
cellular mobilisation being the most commonly antagonised processes 
(Rahwan et al. , 1979). The mode of action of the muscle relaxant 
dantrolene sodium (Section 2.3.2) displays characteristics consistent 
with both extracellular (Putney and Bianchi, 1974; Takauji et al. , 1975; 
Takauji et al. , 1977; Takauji and Nagai, 1977, Yamamoto et al. , 1977) and 
intracellular (Ellis and Bryant, 1972; Ellis and Carpenter, 1972; Hainaut
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and Desmedt, 1974; Van Winkle, 1976; Morgan and Bryant, 1977; Francis, 
1978; Desmedt and Hainaut, 1979) antagonism of calcium fluxes in skeletal 
muscle. This bimodal inhibition of calcium mobilisation by dantrolene 
has been proposed to be concentration dependent with low concentrations 
inhibiting extracellular influx and higher concentrations directly 
antagonising SR calcium release (Putney and Bianchi, 1974; Nelson and 
Denborough, 1977). The in vivo effectiveness of dantrolene in blocking 
the development of the syndrome in susceptible swine (Harrison, 1975, 1977) 
indicates that in MH the primary abnormality resides in the skeletal 
musculature. In vitro drug-induced hypercontractility in MH muscle 
preparations is abolished by pretreatment with dantrolene (Anderson et al. , 
1976, 1978; Okumura et al. , 1980), and the effectiveness of low 
concentrations of dantrolene in attenuating hypercontractility has been 
proposed to reflect antagonism of the E-C coupling step(s) proximal to 
activator calcium release from the terminal cistemae (Nelson and 
Denborough, 1977).
The w-(N,N-diethylamino)-alkyl-3,4,5-trimethoxybenzoates) (TMB) 
constitute a group of compounds which have been widely used as calcium 
ion antagonists in studies of smooth muscle (Malagodi and Chiou,
1974a; Creese, 1979), skeletal muscle (Malagodi and Chiou, 1974b), 
platelets (Charo et al. , 1976a, b; Le Breton and Dinerstein, 1977; 
Rittenhouse-Simmons and Deykin, 1978; Gorman et al., 1979) and leukocytes 
(Matsumoto et al., 1979). Robinson (1971) has shown that as the length 
of the intermediate alkyl chain is increased, not only does the potency of 
these drugs increase, but the dose range for blockage of a wide variety 
of contractile agents in smooth and skeletal muscles narrows as well.
The length of the alkyl chain in the TMB compound is therefore a major 
determinant of potency and tissue specificity (Robinson, 1971). In smooth
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muscle TMB-8 (8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate 
hydrochloride) non-competitively inhibits responses to a number of 
contractile stimuli, but competitive antagonism occurs only in response to 
barium chloride (Malagodi and Chiou, 1974a). Collectively this data 
provides evidence of an intracellular site of action for TMB-8 in smooth 
(Malagodi and Chiou, 1974a) and skeletal (Malagodi and Chiou, 1974b) 
muscles. In addition TMB-8 markedly inhibits caffeine-induced calcium 
release from a skeletal muscle SR preparation, while having no effect on 
calcium uptake rates (Chiou and Malagodi, 1975). Short chain TMB compounds 
possess properties characteristic of cholinesterase inhibitors 
(Robinson, 1971), but the inclusion of physostigmine (a cholinesterase 
inhibitor) in the buffer does not modify the inhibitory effects of TMB-8 
on the contractile responses induced by a number of agents in smooth and 
skeletal muscle preparations (Malagodi and Chiou, 1974a, b).
In platelets TMB-6 and TMB-8 have been shown to markedly depress 
aggregation and secretion induced by a variety of agents (Charo et at. , 
1976a; Le Breton and Dinerstein, 1977; Gorman et at. , 1979) and it seems 
that in these cells TMB compounds 'anchor' intracellular calcium in situ 
(Rittenhouse-Simmons and Deykin, 1978).
In a number of tissues TMB compounds attenuate calcium mobilisation 
in response to diverse stimuli and, although the exact mechanism(s) of 
action are unknown, calcium immobilisation in situ. is the most likely 
mechanism of action. The effects of TMB compounds have not previously 
been assessed on Mil skeletal muscle.
This chapter examines the effects of the calcium ion antagonist 
TMB-8 on halothane-, caffeine-, succinylcholine- and potassium chloride- 
induced contractures in normal and MH porcine skeletal muscle.
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6.2 MATERIALS AND METHODS
6.2.1 Methods
Anaesthesia (Section 3.2.1), the removal of clamped biopsy 
material, the preparation of fibre bundles and the assessment of 
contractile responses (Section 5.2) were carried out as described 
earlier. Experiments were carried out at 37°C in a jacketed organ bath 
under an initial resting tension of 1 gram. A total of 8 normal and 
13 MH swine were biopsied.
Results were expressed as the mean ± S.E.M., and compared using 
the Student’s t-test. A maximum of two fibre preparations per individual 
animal was used for any single or combination drug treatment.
6.2.2 Materials
TMB-8 was synthesised by Dr D.J. Brown, Medical Chemistry Group, 
John Curtin School of Medical Research, Canberra, by the method of 
Malagodi and Chiou (1974a). Stock solutions of TMB-8, 5 and 50 mM, 
were prepared in the modified Ringer buffer. Physostigmine was obtained 
from Sigma Chemical Company. Additional materials were as described in 
Section 5.2.2.
6.3 RESULTS
6.3.1 Drug contractures in porcine skeletal muscle
Contractile responses to 3% halothane, 2 mM caffeine, 1 mM 
succinylcholine and 80 mM KC1 differentiated normal from MH muscle 
(Figure 6.1). 1 mM TMB-8 induced contractures in MH muscle
(1.28 ± 0.22 grams, n = 5) which were significantly different from 
contractures in normal muscle (0.10 ± 0.10 grams, n = 4) (Figure 6.1).
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Tension changes in response to 100 yM TMB-8 were always less than 0.1 grams 
in both muscle types.
6.3.2 Effects of TMB-8 on normal muscle
Contractile responses to 3% halothane, 2 mM caffeine, 1 mM 
succinylcholine and 80 mM KC1 were minimal in normal muscle preparations 
(Figure 6.1) and pre-treatment with 100 yM TMB-8 had no effect on these 
responses. A minimum of 4 muscle preparations was used for any TMB-8-drug 
combination, and for all such combinations contractile responses were 
less than 0.1 grams (results not shown). Isometric twitch was abolished 
by treatment with 1 mM TMB-8 (Figure 6.2D).
6.3.3 Effects of TMB-8 on MH muscle
Figure 6.2 shows the dose dependency of TMB-8-induced contractures 
in MH muscle. Low concentrations of TMB-8 (i.e. 100 yM) enhanced the 
contractile sensitivity of MH muscle to halothane, caffeine and 
succinylcholine. Typical tracings are shown in Figure 6.3. Prior 
treatment with 100 yM TMB-8 significantly increased the magnitude of 
drug contractures induced by 3% halothane (229%), 2 mM caffeine (156%) 
and 1 mM succinylcholine (131%) (Figure 6.4). However this concentration 
of TMB-8 reduced KCl-induced contractures by a factor of 3 (Figure 6.4).
The effectiveness of TMB-8 in blocking KCl-induced contractures 
was concentration dependent with half maximal inhibition occurring at 
approximately 50 yM TMB-8 (Figure 6.5). The inhibitory effect of 100 yM 
TMB-8 on KCl-induced contractures was not modified in a calcium supplemented 
(10 mM) buffer (n = 2).
In addition to potentiating halothane-, caffeine- and 
succinylcholine-induced contractures, 100 yM TMB-8 induced an additional 
contracture when added to halothane or succinylcholine contracted muscle.
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Figure 6.1: Drug-induced contractures in normal and Mil porcine
skeletal muscle
Contractile responses to 3% halothane (HAL), 2 mM caffeine (CAFF),
ImM succinylcholine (SCC), 80 mM KC1, and 1 mM TMB-8 were recorded under 
an initial resting tension of 1 gram. Contractile responses are shown for 
normal (diagonal bars) and MH (closed bars) fibre preparations. Standard 
errors are not included for normal muscle responses as S.E.M.s were always 
$ 0.01 grams.
** p < 0.01 
*** p < 0.001
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Figure 6.2: Contractile responses of MH porcine skeletal muscle to TMB-8
These tracings show the contractile responses of individual MH fibre 
preparations to increasing concentrations of TMB-8 (traces, A, B, and C).
The effect of 1 mM TMB-8 on normal muscle is shown for comparison (trace D).
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Figure 6.3: Modification of halothane-, caffeine-, succinylcholine- and
KC1 -induced contractures by TMB-8 (100 yM) in MH porcine 
skeletal muscle
Typical responses are shown for 3% halothane (HAL), 2 mM caffeine (CAFF),
1 mM succinylcholine (SCC) and 80 mM KC1 (traces Al, Bl, Cl and Dl, 
respectively). TMB-8 (100 yM) was added where indicated and drugs added 
10 minutes after this (A2, B2, C2 and D2). Trace A3 shows the potentiating 
effect of 3% halothane on 100 yM TMB-8-induced contractures. Each trace 
represents a separate fibre preparation.
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3% HAL 2m M CAFF ImM SCC 80mM KCl
Figure 6.4: Effect of TMB-8 (100 yM) on the contractile responses of
MH porcine skeletal muscle to halothane, caffeine, 
succinylcholine and KCl
Contractile responses to 3% halothane, 2 mM caffeine, 1 mM succinylcholine, 
and 80 mM KCl (closed bars) are shown in Figure 6.1. TMB-8 (100 yM) was 
added 10 minutes prior to each drug and the maximum tension generated 
recorded (horizontal bars). Abbreviations for drugs are as shown in 
Figure 6.1. Each observation represents a separate fibre preparation.
** p < 0.01 
*** p < 0.001
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Figure 6.5: Inhibition of KCl-induced contractions in MH porcine skeletal
muscle by TMB-8
The traces show contractile responses to KC1 (80 mM, arrows indicate when 
added) in the absence or presence of increasing concentrations of TMB-8. 
TMB-8 (at the concentrations indicated) was added 10 minutes prior to KC1. 
Each trace represents a separate fibre preparation.
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The addition of 100 yM TMB-8 to halothane treated muscle (Figure 6.3A3) 
resulted in a contracture (1.42 ± 0.20 grams, n = 17), and a similar 
result was recorded in succinylcholine treated muscle (0.40 ± 0.16 grams, 
n = 6). By comparison 100 yM TMB-8 alone had no effect on MH muscle 
( < 0.1 grams, n = 37). The addition of 100 yM TMB-8 after a KCl-induced 
contracture had no effect on muscle tension (n = 6). Potentiation of 
TMB-8-induced contractures by caffeine was not investigated.
Physostigmine (0.5 yM) was added to the buffer on a number of 
occasions but the hyperreactive responses in MH muscle preparations were 
not altered in its presence (results not shown).
6.3.4 Attenuation of TMB-8 induced hyperreactivity in MH porcine 
skeletal muscle
Glycerol-induced detubulation abolished both the contractile 
effect of 1 mM TMB-8 and the drug contractile potentiating effect of 
100 yM TMB-8 in MH muscle preparations. In MH muscle the E-C coupling 
antagonist dantrolene sodium (6 yM) completely abolished;
(1) 100 yM TMB-8-induced potentiation of halothane-induced 
contractures (Figure 6.6A) (n = 3);
(2) halothane-induced potentiation of 100 yM TMB-8 induced 
contractures (Figure 6.6B) (n = 2);
(3) the contracture induced by 1 mM TMB-8 (Figure 6.6C) (n = 2). 
Contractility in response to 1 mM TMB-8 was abolished by a 30 minute 
incubation in a 2 mM EGTA, calcium free buffer (n = 2).
6.4 DISCUSSION
The hyperreactivity that characterises MH skeletal muscle on 
exposure to TMB-8 contrasts with the inhibitory effect on drug-induced
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Figure 6.6: Inhibition of TMB-8-induced hyperreactivity in MH porcine
skeletal muscle by dantrolene sodium 
Potentiation of 3% halothane-induced contractures by 100 yM TMB-8 
(trace Al) and of 100 yM TMB-8-induced contractures by 3% halothane 
(trace Bl) was completely abolished by 6 yM dantrolene (traces A2 and B2, 
respectively). 1 mM TMB-8-induced contractures (trace Cl) were also
abolished by 6 yM dantrolene (trace C2). Abbreviations for drugs are as 
shown in Figure 6.1. Each trace represents a separate fibre preparation.
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contractures in a variety of muscle tissues. In smooth (Malagodi and 
Chiou, 1974a) and skeletal (Malagodi and Chiou, 1974b) muscles TMB-8 
non-competitively inhibits contractile responses to agents that act on 
the surface membrane (e.g. acetylcholine, KC1, direct and indirect 
electrical stimulation, and nicotine), while competitive antagonism 
characterises the effects of TMB-8 on contractures induced by agents 
which have an intracellular site of action (e.g. caffeine and barium 
chloride). Non-competitive inhibition occurs at low doses, while 
5- to 10-fold higher concentrations of TMB-8 are required to competitively 
antagonise the direct action of barium chloride and caffeine on intra­
cellular calcium release in smooth and skeletal muscles, respectively 
(Malagodi and Chiou, 1974a, b).
In frog skeletal muscle the slow diffusion of TMB-8 into intra­
cellular membrane sites has been proposed to underly the requirement for 
high doses of TMB-8 to inhibit caffeine contractures (Malagodi and Chiou, 
1974b) and this proposal is supported by the effectiveness of low doses 
of TMB-8 (i.e. 5 yM) in inhibiting the release of 45Ca2+ by caffeine from 
an isolated skeletal muscle SR preparation (Chiou and Malagodi, 1975).
In normal porcine skeletal muscle contractures were not induced 
by 3% halothane, 2 mM caffeine, 1 mM succinylcholine or 80 mM KC1 in the 
absence or presence of 100 yM TMB-8. In MH muscle the inhibitory effects 
of low doses of TMB-8 (< 100 yM) on KCl-induced contractures accords with 
the concentrations required to inhibit KCl-induced contractures in a variety 
of skeletal muscle preparations (Malagodi and Chiou, 1974b).
The inability of low doses of TMB-8 to antagonise halothane-, 
caffeine- or succinylcholine-induced contractures suggests that in MH 
muscle these drugs do not act on the sarcolemma. The similarity between
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MH muscle responses in the presence or absence of physostigmine rules out 
the possible inhibition of acetylcholinesterase as an explanation of 
TMB-8-induced hyperreactivity in MH muscle preparations. The rapidity with 
which contractures develop in response to 1 mM TMB-8 argues against an 
intracellular site of action since, in intact muscle, the effect of 
TMB-8 on SR membranes has been proposed to be time dependent with up to 
20 minutes required for full expression (Malagodi and Chiou, 1974b).
Thus in MH muscle TMB-8 appears to exert its'abnormal effects distal to 
the sarcolemma and proximal to SR calcium release (i.e. at the level of 
the triad). The effectiveness of E-C uncoupling treatments (i.e. prior 
glycerination or pretreatment with dantrolene sodium) in abolishing 
TMB-8-induced hyperreactivity is also consistent with a triadic site of 
action.
The mechanism by which TMB-8 immobilises calcium remains obscure 
but the lack of highly charged functional groups on the TMB-8 molecule 
(Figure 6.7) would suggest that a direct interaction with calcium is 
unlikely. A direct interaction of TMB-8 with biological membranes is an 
alternative mechanism of action, and is consistent with the structure and 
length of the molecule. The length of the TMB-8 molecule approximates to 
the half width of a synthetic phospholipid bilayer and the hydrocarbon 
diethylamino-octyl side chain could conceivably become inserted parallel 
to the phospholipid fatty acids with the bulky trimethoxybenzoyl group 
stabilised by hydrogen bonding between the carboxyl group and the polar 
head groups of the phospholipids. This interaction is schematically 
illustrated by Figure 6.7. Stabilisation of the membrane might be the 
likely result of this TMB-8-phospholipid interaction and the slow rate of 
transverse diffusion of TMB-8 across the membrane (Malagodi and Chiou, 
1974b) might reflect its rigid deposition in the lipid bilayer. A similar
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TMB-8 Coenzyme Q-3
Figure 6.7: Hypothetical localisation of TMB-8 within a phospholipid
membrane
The structural similarities between TMB-8 and Coenzyme Q-3 are shown in 
the upper section of the figure. Below is shown a possible site of action 
of TMB-8 in a phospholipid membrane.
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site of action has been proposed for the synthetic ubiquinone, Co-enzyme 
Q-3 (Lenaz et al. , 1978a). The site of action of TMB-8 as shown in 
Figure 6.7 is relatively non-specific; other interactions might occur 
which would confer a greater degree of specificity. These might include;
(1) a direct interaction between TMB-8 and specific membrane 
proteins (e.g. calcium binding proteins);
(2) an indirect effect of TMB-8 on membrane proteins, 
mediated by an interaction between the drug and the 
’layer' or 'annulus' of phospholipids which surround 
specific membrane proteins. This represents a more 
specific interaction than that described in Figure 6.7.
Although such a model would be consistent with the effects of 
TMB-8 in a number of normal tissues it is difficult to explain the initial 
hyperreactivity that occurs in MH muscle on exposure to TMB-8 in terms of 
such a model. It is possible that the hyperreactive effect of TMB-8 on 
MH muscle has little to do with its function as a calcium antagonist and 
that the interaction of the drug with the T-tubular membrane in some way 
facilitates or itself directly initiates the release of trigger calcium 
(Endo, 1977; Ebashi, 1979). Thus the mechanism by which TMB-8 contracts 
and potentiates drug-induced contractures remains obscure but this drug 
provides a useful tool to further study the nature and site of the 
skeletal muscle abnormality in MH.
6.5 SUMMARY
TMB-8 contracted porcine MH skeletal muscle and potentiated the 
contractile actions of 3% halothane, 2 mM caffeine, and 1 mM succinylcholine. 
80 mM KCl-induced contractures were antagonised by TMB-8. E-C uncoupling
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treatments abolished TMB-8-induced hyperreactivity. Immobilisation of 
calcium in situ appears to underlie the mode of action of TMB-8 in 
normal muscle but the mechanism underlying TMB-8-induced hyperreactivity 
in MH muscle remains obscure.
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CHAPTER 7
PLATELET FUNCTION IN MALIGNANT HYPERPYREXIA
7.1 INTRODUCTION
7.1.1 Platelet structure and function
The platelet possesses a number of structural and functional 
characteristics similar to those of skeletal muscle, including a muscle- 
type contractile system and a complete dependence on calcium for normal 
functioning (White and Gerrard, 1978; White, 1979). Stimulus-secretion 
coupling, the process whereby stimulation of the surface membrane is coupled 
to eventual secretion of intracellular contents, is similar to E-C coupling 
in skeletal muscle (Day and Holmsen, 1971; Barnhart, 1978). Structurally 
the platelet is complex, and consists of three discrete regions or zones; 
the peripheral zone, the sol-gel zone and the organelle zone (Henry, 1977; 
White, 1979). The peripheral zone consists of the plasma membrane and 
surface connected canalicular membrane, and its chemical constituents 
modulate specificity for stimuli triggering platelet activation (White, 
1979). The sol-gel zone constitutes the matrix of the platelet cytoplasm 
and contains the contractile protein systems which maintain the discoid 
shape of the resting or unchallenged platelet and modulate shape change, 
internal contraction and secretion in the stimulated platelet (Henry,
1979; White, 1979). The organelle zone contains a specialised group of 
secretory vesicles which include dense bodies, a-granules and lysosomal 
vesicles (Holmsen and Weiss, 1979).
Upon stimulation the signal initiating the changes in the platelet 
surface membrane may or may not be translated and amplified through the 
membrane, depending on the nature and the level of stimulation employed.
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When platelets are exposed to aggregating agents in vitro the change in 
surface membrane properties results in the eventual formation of aggregates. 
This process of aggregate formation reflects an increase in platelet 
"stickiness" (White, 1979). Above a certain threshold level of stimulation 
the aggregating signal is propagated into the cell and activation of the 
platelet contractile machinery results in the mobilisation, fusion and 
active extrusion of secretary vesicle contents through the surface-connected 
canalicular system. The release reaction represents the final stage in the 
activation process and the released products (particularly ADP) in turn 
transmit the signal to surrounding, unstimulated platelets, causing 
further aggregation.
Platelets contain both metabolic and storage pools (dense granule 
localised) of adenine nucleotides and the distribution of the nucleotides 
is characteristic for each pool (Holmsen and Weiss, 1979). In normal human 
platelets approximately 65% of the total content of adenine nucleotides 
are stored in the dense granules where the ratio of ATP to ADP is 2:3 
(Holmsen and Weiss, 1979). In the metabolic pool ATP predominates and 
the ATP/ADP ratio may be greater than 8 (Holmsen and Weiss, 1979).
Storage pool diseases constitute a broad group of disorders which are all 
associated with the abnormal storage and/or release of constituents from 
the dense granules. In such individuals the failure to release intra­
cellular platelet constituents (i.e. serotonin and non-metabolic adenine 
nucleotides) is due to a deficiency in the number of dense granules (Lusher 
and Barnhart, 1977).
An additional group of disorders has been described where the 
release mechanism is defective, despite a normal storage pool (Deykin,
1974; Walsh and Gagnatelli, 1974). Defective release characterises 
aspirin treated platelets and this supports the conclusion that the release
128
defect has some characteristics in common with the effect of aspirin on 
normal platelets (Paratti et at. , 1974). Acetylation of the 
cyclooxygenase enzyme represents the primary site of action of aspirin 
(Roth and Majerus, 1977) and this results in a block in the arachidonic 
acid cascade at a step prior to the formation of the potent aggregatory 
endoperoxides and thromboxanes (Harris et at. , 1979).
Platelet aggregation is usually studied in vitro using the 
turbidometric method first developed by Born (1962). Despite the in vitro 
nature of the test its application has provided substantial and useful data 
on platelet function in both the normal and diseased states (Lusher and 
Barnhart, 1977; Barnhart, 1978). Platelet aggregation may be reversible 
or irreversible and monophasic or biphasic depending on the nature and 
strength of the stimulus employed. The second phase of biphasic aggregation 
is associated with the occurrence of the release reaction (Charo et at. , 
1977, Barnhart, 1978) and its inhibition by the cyclooxygenase inhibitor 
aspirin, suggests that secondary aggregation, the release reaction and 
the generation of prostaglandin and endoperoxide metabolites are closely 
linked phenomena.
7.1.2 Platelet function in malignant hyperpyrexia
Platelet aggregatory responses have been characterised in a number 
of studies in an attempt to correlate MH susceptibility with a clinically 
demonstrable platelet abnormality (Isaacs, 1978; Zsigmond et at., 1978).
A number of susceptible individuals have shown decreased responsiveness 
to aggregatory agents, especially adrenaline and collagen (Isaacs, 1978; 
Zsigmond et at., 1978). Secondary aggregation, and the associated release 
reaction, in response to adrenaline was absent in 2 out of 13 (Isaacs, 1978) 
and 5 out of 8 (Zsigmond et at. , 1978) patients screened by these
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investigators. Ristocetin-and ADP-induced aggregation was always normal 
(Zsigmond et at., 1978). Aggregatory responses to arachidonic acid, 
thrombin, or to the calcium ionophore A-23187 have not been assessed in 
MU platelets. It would appear therefore that abnormal aggregation is a 
feature found in some susceptible individuals but the presence of borderline 
to normal responses in others questions the usefulness of this method in 
assessing MH susceptibility (Isaacs, 1978).
Platelet synthesis of purine nucleotides is modified in the 
presence of halothane and this effect is most dramatic in platelets from 
MH susceptible individuals (Solomons et at. , 1978). Utilising radioactive 
14C-labelled adenine, Solomons has shown that halothane alters the nucleotide 
synthesising capabilities of MH platelets and results in an abnormally low 
ratio of 14C-ATP + 14C-ADP/14C-AMP (i.e. $ 3) in MH susceptile 
individuals (Solomons et at, , 1978). Comparable experiments with normal 
platelets gave a ratio greater than 8 (Solomons et at. , 1978). This 
decreased capacity for synthesis of adenine nucleotides in the presence of 
halothane represents a useful link to the MH skeletal muscle response where 
halothane rapidly depletes ATP levels in vitro (Section 2.3.7).
This chapter examines the effects of a variety of aggregating 
agents on MH platelets in an attempt to develop a simple, nontraumatic 
procedure with which to assess MH susceptibility. The aggregatory effects 
of ADP, collagen, adrenaline, thrombin, arachidonic acid, and A-23187 
on MH platelets have been examined in some detail, and the results correlated 
with the in vitro pharmacological assessment of susceptibility on the basis 
of drug-induced contractures in isolated skeletal muscle preparations.
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7.2 MATERIALS AND METHODS 
7.2.1 Methods
Blood was collected atraumatically via a 21 gauge butterfly cannula 
with a 12 inch extension tube. 9 vol of blood were collected into 1 vol 
of citrate (0.1 M trisodium citrate, pH 7.4). Platelet-rich plasma 
(PRP) was prepared by centrifugation at 100 g for 15 minutes at room 
temperature. PRP was stored in stoppered syringes at 37°C and aggregation 
experiments were completed within three hours of blood collection. 
Platelet-poor plasma (PPP) was prepared from PRP by centrifugation at 
8000 g for two minutes at room temperature. Patients were requested to 
abstain from ingesting medications known to influence platelet behaviour 
for at least ten days prior to blood collection (Barrer and Ellison, 1977; 
Verstraete, 1978).
Platelet counts in PRP were performed on a Model ZF Coulter 
Counter (Coulter Electronics, England). PRP samples (5 yl) were added to 
15 ml of isoton (Coulter Electronics) and counted within 30 minutes of 
dilution. Values are given as means ± S.D.
Platelet aggregation was monitored turbidometrically (Born, 1962) 
using a Payton dual channel Aggregation Module (Payton Association Ltd, 
Canada). The following stock solutions were maintained; ADP, 10 mM in 
reagent diluent (RD); adrenaline bitartarate, 10 mM in RD; collagen, 1 mg/ml 
in acetic acid; bovine thrombin, 1000 units/ml in RD; potassium 
arachidonate, 14.5 mM in RD; A-23187, 2 mg/ml in DMSO. Stock solutions of 
collagen and A-23187 were stored at 4°C; all others were stored at -20°C.
RD contained 147 mM NaCl, 2.7 mM KC1, 9.4 mM NallCOj and 0.42 mM Na^POi*; 
pH 7.4 and was prepared fresh each day. Prior to use, working dilutions 
were prepared from the stock solutions and maintained on ice during use.
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The release reaction was assessed by measuring the release of 
radioactivity from platelets previously labelled with 3H-serotonin 
(5-hydroxytryptamine binoxalate-3H ; 25 Ci/mmol. PRP was incubated with
3H-serotonin (0.3 yCi/ml of PRP) at 37°C for 30 minutes. The release 
reaction was stopped by the addition of paraformaldehyde (Costa and Murphy, 
1975) and radioactivity was determined in PPP and PRP samples. The samples 
(100 yl) were added to 15 ml of scintillation mixutre (Bray, 1960) and 
counted in a Packard Tri-carb Liquid Scintillation Spectrometer. The 
released 3H-serotonin was expressed as a percentage of the total radioactivity 
in the PRP.
Electron microscopy was carried out on pelleted platelet fractions 
essentially as described in Section 3.2.5.
7.2.2 Materials
Patients were referred to Dr M.A. Denborough for assessment of MH 
susceptibility by recognised pharmacological criteria (Moulds and 
Denborough, 1974a) . This involved the in vitro exposure of isolated 
skeletal muscle preparations to 3% halothane, 2 mM caffeine, 1 mM 
succinylcholine and 80 mM KC1. Abnormal contractures to the aforementioned 
drugs differentiated MH susceptible from normal individuals.
ADP, collagen (from bovine achilles tendon) and arachidonic acid 
(99% pure) were obtained from Sigma Chemical Company. Adrenaline 
bitartarate was from Calbiochem, and bovine thrombin from Parke Davis.
A-23187 was kindly supplied by Eli Lilly Research Laboratories and 
3H-serotonin was obtained from New England Nuclear.
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7.3 RESULTS
7.3.1 Platelet counts
Platelet counts varied from 165,000 to 602,500 /yl in normal PRP 
(Table 7.1) and from 238,600 to 623,400 /yl in MH PRP (Table 7.2).
Average counts were significantly higher in MH PRP (normal = 341,100 ± 
98,600 /yl, n = 13, and MH = 435,100 ± 96,000 / yl, n = 19; p < 0.05).
7.3.2 Platelet aggregation
Normal aggregation responses to a variety of agents are shown in 
Figure 7.1. The range of threshold concentrations of arachidonic acid 
(0.29 to 0.73 mM), thrombin (0.05 to 0.2 units/ml) and A-23187 (5 to 
20 yg/ml) required to induce irreversible aggregation were similar in 
normal and MH PRP. Excluding patient B.R. (Table 7.2) both normal and 
MH platelets responded normally to ADP (range, 1 to 10 yM). However 
responses to adrenaline and collagen varied considerably and 3 response 
groups could be identified with some overlap between the normal and MH 
subjects (Tables 7.1 and 7.2).
(a) Group 1; irreversible aggregation in response to 1 yM 
adrenaline and 0.25 yg/ml collagen (Figure 7.1) characterised platelet 
responses in this group. Platelets from six normal (Table 7.1) and four 
MH (Table 7.2) individuals gave Group 1 responses.
(b) Group 2; an absence of first phase and a considerable delay 
in the onset of aggregation characterised adrenaline responses in this 
group (Figure 7.2A) and/or responses to collagen were also considerably 
reduced (Figure 7.2A). Platelets from seven normal (Table 7.1) and 
fourteen MH (Table 7.2) individuals gave Group 2 responses.
(c) Group 3; in one MH patient (B.R.; Table 7.2) ADP, adrenaline 
and collagen failed to induce irreversible aggregation (Figure 7.3) even
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Figure 7.1: Group 1 platelet aggregation and release responses
The final concentrations of the aggregatory agents used were as 
follows: ADP, 2.5 yM; adrenaline (ADR), 1 yM; collagen (COLL),
0.25 yg/ml; arachidonic acid (AA), 0.6 mM; A-23187, 20 yg/ml; 
thrombin (THR), 0.1 units/ml. Release of 3H-serotonin is indicated 
at the end of each tracing. Aggregation responses were typical for all 
Group 1 patients but 3H-serotonin release was only monitored in patient Y.M.
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Figure 7.2: Group 2 platelet aggregation and release responses
The final concentrations of aggregatory agents used were as described 
in Figure 7.1. Aggregation in response to arachidonic acid, A-23187 
and thrombin was similar to Group 1 platelets. The % release of 3H- 
serotonin refers to patient J.R. only.
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Figure 7.3: Group 3 platelet aggregation and release responses
The final concentrations of aggregatory agents used were as described 
in Figure 7.1. Aggregation in response to arachidonic acid, A-23187 and 
thrombin was similar to Group 1 platelets. Group 3 responses were found 
only in one patient, B.R., an MH susceptible individual.
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Table 7.2: 
Platelet aggregation and platelet counts in MH susceptible humans
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at very high concentrations (e.g. ADP, 10 yM; adrenaline, 10 yM; 
collagen, 20 yg/ml). The failure of these agents to aggregate B.R.'s 
platelets contrasts with the normal aggregatory behaviour displayed in 
response to thombin, arachidonic acid, and A-23187 and indicates that these 
platelets are characterised by a release defect.
7.3.3 Platelet release reaction
3II-serotonin release was monitored in B.R. (Group 3, Figure 7.3) 
on three separate occasions, and on all occasions, ADP (2.5 yM), adrenaline.
(1 yM) and collagen (0.25 yg/ml) failed to induce any release of radioactivity.
Percentage release of 3H-serotonin from Y.M.'s platelets (Group 1) 
and from J.R.'s platelets (Group 2) was essentially similar in response 
to ADP, (percentages in Figures 7.1 and 7.2, respectively), and failed to 
differentiate these two groups. Release of 3H in response to thrombin, 
arachidonic acid, and A-23187 was similar in each of the three groups.
In all of the patients tested !3H-serotonin uptake reached a maximum within 
15 minutes and was maintained over a ninety minute period.
7.3.4 Electron microscopy
The high concentration of dense granules in the platelets of B.R. 
are similar to the numbers found in normal platelets (Figure 7.4).
The addition of 10 yM adrenaline (approximately 5-10 times the concentration 
required to aggregate Group 1 platelets) had little effect on B.R.'s 
platelets while the normal platelets displayed extensive aggregation and 
release of intracellular contents (Figure 7.5).
7.4 DISCUSSION
In the present investigation abnormal platelet aggregation was
Figure 7.4: Platelet morphology in an MH susceptible and a normal
individual
The upper micrograph shows platelets isolated from an MH susceptible 
patient (B.R., Table 7.2 and Figure 7.3). The lower micrograph shows 
platelets isolated from a normal individual. Morphological details 
are similar. The designated structural features comprise: the
surface connected canalicular system (CS), dense bodies (DB), the 
dense tubular system (DTS), specific storage granules (G), 
glycogen granules (Gly) and mitochondria (M). Magnification: 
upper, x 10,000; lower, x 13,000.
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Figure 7.5: Effect of adrenaline on platelet morphology in an Mil
susceptible and a normal individual
Platelets were pelleted and fixed 5 minutes after the addition of
10 yM adrenaline. The upper micrograph shows adrenaline treated
platelets from an MH susceptible patient (B.R., Table 7.2 and Figure
7.3) and the lower micrograph adrenaline treated platelets from a
normal individual. Aggregation and release did not occur in B.R.’s
platelets while in normal platelets adrenaline induced irreversible
aggregation and release (as evidenced by pseudopod formation and a
decrease in granules). Magnification: upper, x 8,000; lower, x 13,000.
1 4 0
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demonstrated in a large number of individuals shown to be susceptible to 
MH, but there was considerable overlap between platelet responses in 
normal and MH subjects. In a random study in South Africa, involving 
several members of families known to be MH susceptible, abnormal platelet 
aggregation was shown in many carriers but, as in this study, normal 
responses were also recorded in some susceptible individuals (Isaacs,
1978). Details regarding the nature of these abnormal responses have not 
been reported, but it would appear that irreversible aggregation in response 
to collagen and adrenaline did occur but that higher concentrations of the 
agents than normal were required to bring about this effect (Isaacs, 1978). 
The Group 2 responses described here best approximate to the abnormal 
platelet responses reported by Isaacs (1978). Separate studies on two 
MH susceptible families in Michigan (Zsigmond et at. , 1978) identified 
additional variations on these abnormal aggregation patterns. In one 
family, secondary aggregation was not observed in response to adrenaline 
or collagen while in the second family, only adrenaline failed to induce 
secondary aggregation. The variety of aggregating responses reported for 
MH individuals in this and other studies (Isaacs, 1978) may reflect 
methodological differences, but such a possibility seems unlikely. A more 
likely explanation is that this variability in platelet responses reflects 
heterogeneity in the types of cell affected, and/or the degree of 
expression of the abnormality in any single cell type.
Abnormalities in platelet function are associated with either 
hypo- or hyperreactivity (White and Gerrard, 1978) and the abnormality 
(when expressed) in MH platelets falls within the former category.
Decreased platelet activity is a characteristic feature of a number of 
congenital disorders including Bemard-Soulier syndrome, von Willebrand’s 
disease, thrombasthenia, and the heterogeneous storage pool diseases
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(Lusher and Barnhart, 1977; White and Gerrard, 1978). The nature of 
the abnormality underlying the Group 2 platelet response (i.e. no first 
phase to adrenaline and decreased collagen-induced aggregation) remains 
obscure, but the delay and decreased responsiveness to specific agents 
may reflect a direct surface membrane abnormality and/or an indirect 
functional decrease in the transmission of the activation stimulus from 
the surface membrane to the rest of the platelet. The normal ADP, 
thrombin, arachidonate and A-23187 mediated aggregation responses further 
support such a selective abnormality.
Group 3 responses display many features indicative of a release or 
aspirin-like defect. The failure to aggregate and undergo the release 
reaction (despite the normal complement of secretory products) in response 
to ADP, adrenaline and collagen is common to a number of congenital 
connective tissue disorders (Estes, 1972; Hathaway et at., 1972), and in 
one of these, namely osteogenesis imperfecta (01) the abnormality is 
thought to be diffuse affecting many cell types, including leukocytes and 
platelets (Hathaway et at. , 1972) . Platelet aggregation and release in 
response to thrombin, A-23187, and in an individual (K.C.) susceptible to 
01 displayed a similar response profile to that shown by MH patient B.R.
(J. Sullivan, N.G. Ardlie and M.A. Denborough, unpublished results).
The abnormal metabolism of adenine nucleotides in both MH (Solomons et at. , 
1978) and 01 platelets (Hathaway et at. , 1972) further underlines the 
similarities and the generalised nature of each of these syndromes.
Electron micrographs show that B.R.'s platelets contain normal levels of 
dense bodies (Figure 7.4) and together with the demonstrated ability of 
thrombin, arachidonate, and A-23187 to induce serotonin release, indicate 
that these platelets display characteristics consistent with a release 
defect (Luscher and Barnhart, 1977). Group 3 responses have also been
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described in two additional MH susceptible individuals (N.G. Ardlie and 
M.A. Denborough, unpublished results) indicating that the release defect 
characteristic of B.R.’s platelets may be more widespread than was 
suggested by this current study. The overlap in platelet aggregation 
responses between normal and MH individuals limits the application of 
platelet function tests in assessing MH susceptibility. Additionally, the 
sensitivities of the platelet to a wide variety of drugs (Barrer and 
Ellison, 1977; Verstraete, 1978) necessitates the carrying out of such 
tests under conditions where the ingestion of drugs by patients is strictly 
controlled. The demonstrated abnormalities in platelet aggregation 
responses in a large number of MH susceptible individuals further under­
lines the generality of the defect predisposing to MH. However the 
variable presence and extent of the platelet abnormality limits the use 
of platelet function tests in assessing MH susceptibility. Furthermore 
the occurrence of normal platelet aggregation in individuals unambiguously 
identified as being MH susceptible, together with the ability of a wide 
variety of drugs to alter aggregation responses in normal individuals 
(Barrer and Ellison, 1977; Verstraete, 1978) indicates that platelet 
function tests alone should not be used to identify individuals at risk 
for MH.
7.5 SUMMARY
In this investigation abnormal aggregation responses occurred in 
fifteen of the nineteen MH susceptible individuals screened, although in 
only one of these fifteen was the ability to aggregate in response to ADP, 
abolished. In the remaining fourteen a diminished response to adrenaline 
and collagen characterised susceptible individuals. Seven of the thirteen 
normal individuals screened displayed decreased aggregatory responses to 
adrenaline and to collagen. Under conditions where the ingestion of drugs
144
is strictly controlled, platelet function tests serve as an additional 
method to complement currently available techniques in assessing MH 
susceptibility. In isolation such tests should not be used to identify 
individuals at risk for MH.
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CHAPTER 8
GENERAL DISCUSSION
8.1 INTRODUCTION
The studies presented in this thesis were undertaken to further 
characterise the nature of the abnormality predisposing to MH. A multi­
disciplinary approach was adopted in which biochemical, pharmacological 
and biophysical techniques were used to achieve this objective.
8.2 GENERAL DISCUSSION
Earlier investigations on MH clearly implicate skeletal muscle as 
the primary affected tissue. Within this tissue it appears that the 
underlying abnormality is directly associated with the processes modulating 
intracellular calcium concentration and/or distribution, although there is 
still no direct evidence to support this view. The most important level 
of control of calcium ion movements in cells is carried out by cell 
membranes, and an abnormality in the processes modulating intracellular 
calcium concentrations could reflect a structural and/or functional 
abnormality at the membrane level. In the case of skeletal muscle a variety 
of membrane linked processes have been implicated (Chapter 2). Despite the 
evidence favouring a variety of functional abnormalities in discrete 
subcellular muscle fractions, few studies have attempted to correlate 
abnormal function to an underlying structural abnormality. Such an 
approach was adopted in this study and the chemical composition of normal 
and MH muscle membranes was presented in Chapter 3. These findings 
suggest that there are no consistent changes in membrane composition in MH 
skeletal muscle. A decrease in the unsaturated fatty acid content of
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membrane phospholipids and an increase in the levels of cholesterol were 
found in MH trapezius muscle, but the similar composition of normal and 
MH 1. dorsi muscle suggests that the changes in the lipid composition of 
the trapezius muscle probably reflect a secondary phenomenon.
The protein profiles of the muscle membrane fractions characterised 
in the present study were complex (Section 3.3.6) and contrast with the 
simpler profiles for porcine skeletal muscle membranes obtained by 
McIntosh et at. (1977). Differences in acrylamide gel composition and the 
use of a cylindrical disc gel electrophoretic system might account for 
the simpler muscle membrane protein profiles obtained by McIntosh et al. 
(1977). Indeed the running of comparable muscle membrane fractions on disc 
and slab gels demonstrated the greater resolving power of the latter 
electrophoretic system (J. Sullivan and M.A. Denborough, unpublished 
results). Although cross contamination between various membrane systems 
cannot be ruled out as an explanation for the complex electrophoretic 
patterns, the results from the present investigation suggest that the 
simpler protein profiles reported for skeletal muscle membranes using disc 
gel electrophoresis might reflect the limitations of this electrophoretic 
method. Further work is required to clarify this point.
Consistent quantitative or qualitative abnormalities in membrane 
protein composition were not found in either the red trapezius or the white 
1. dorsi muscles from MH swine. This appears to rule out a gross alteration 
in muscle membrane protein composition as the primary cause of MH, but a 
more subtle protein abnormality in a discrete membrane system cannot be 
ruled out. Further purification of the membrane fractions isolated in 
the present study would be required to assess such a possibility.
Elevations in body temperature represent an important clinical
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feature during the development of MU (Denborough, 1979) the skeletal 
muscle plays a major role in this process (Lucke et dl., 1979). As body 
temperature rises the development of the syndrome, within skeletal muscle, 
becomes self sustaining since the increased temperature reduces the calcium 
requirement for actinomyosin cross-bridge formation (Fuchs, 1975), SR 
calcium uptake (Britt et al. , 1975) and ATP synthesis (Britt, 1979).
Thus the elevation in muscle temperature represents a key event in MH and 
in Chapters 4 and 5 controlled variations in temperature were exploited 
to study two different aspects of muscle function. In Chapter 4 the 
functional aspects of isolated muscle membranes were characterised using 
NMR spectroscopy.
In model phospholipid membranes NMR provides simultaneous 
information on the surface, hydrocarbon and middle regions of the membrane 
bilayer. Peak height and width are related to the molecular mobility of 
individual proton groups and this property in turn reflects the physical 
state (i.e. solid or fluid) of the membrane bilayer. The -^H spectra of 
both the microsomal membranes and the sonicated lipid extracts gave 
similar well resolved methylene and methyl resonances, indicating that 
proteins do not appreciably alter lipid mobility in the muscle membrane.
As there are many non-phospholipid containing fatty acid molecules (i.e. 
mono-, di- and triglycerides) in the membrane and lipid extracts the 
contribution of glycerides to the methylene and methyl resonances must 
also be considered. Elevations in temperature generally sharpen 
phospholipid proton resonances in model and biological membranes (reviewed 
in Chapter 4) and the small effects of temperature on the spectra 
obtained in the present study are consistent with the view that non­
phospholipids are contributing to the *11 spectrum. In the absence of 
specific structural and/or functional roles for non-steroidal neutral
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lipids in biological membranes the possible significance of their 
occurrence in the fractions characterised here remains obscure.
In isolated cut-fibre preparations the controlled variation of 
temperature produced dramatic changes in the muscle response to a variety 
of agents and such effects readily differentiated normal from MH muscles 
(Chapter 5). There was a significant decrease in the contractile 
responses of MH muscle preparations to halothane, caffeine, succinylcholine 
and KC1 in the 20 to 25°C temperature range compared to the responses 
obtained at 37°C. The mechanism by which lower temperatures reduce MH 
skeletal muscle hyperreactivity is unknown. Alterations in the physical 
state of the muscle membrane might explain this decrease in hyperreactivity 
but Hl NMR spectroscopy failed to detect significant differences in the 
organisation of MH muscle membranes over a wide temperature range (Section 
4.3.2) indicating either
(i) fluidity differences do not differentiate MH from 
normal muscle membranes or,
(ii) the *H NMR techniques that were employed were not 
sufficiently sensitive to detect organisational 
differences in the membrane preparations.
Recent work has shown that MH porcine skeletal muscle is partially 
depolarised on exposure to halothane (Gallant et al. , 1979; G. Galloway,
J. Bornstein, J. Sullivan and M.A. Denborough, unpublished observations) 
and together with a lower mechanical threshold (Anderson and Bryant, 1977) 
this provides a rational explanation for the hyperreactivity that 
characterises MH skeletal muscle (Section 3.2.2). Neither the partial 
depolarisation (G. Galloway, J. Bornstein, J. Sullivan and M.A. Denborough, 
unpublished results) nor the halothane-induced contractures (Section 5.3.2) 
vere obtained at room temperature suggesting that the two phenomena may be
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related. The effects of lower temperatures on the mechanical threshold 
of MH muscle have yet to be investigated.
Antagonists of calcium ion movements have been used in a variety 
of clinical and experimental studies on Mil (Section 6.1). In particular, 
the muscle relaxant dantrolene sodium has been used successfully to 
attenuate the syndrome in vivo and to block hypercontractility in vitro 
(Section 6.1). The ability of dantrolene to abolish drug-induced 
hypercontractility in MH muscle contrasts with the hyperreactive effects 
of TMB-8 (Chapter 6). The calcium ion antagonist TMB-8 has been shown to 
block drug-induced contractures in a variety of smooth and skeletal muscle 
preparations (Malagodi and Chiou, 1974a, b; Chiou and Malagodi, 1975) 
but TMB-8 contracted at high concentrations and potentiated drug-induced 
contractures at low concentrations in MH porcine skeletal muscle (Chapter 6). 
These effects of TMB-8 are clearly inconsistent with the mode of action of 
a calcium ion antagonist and it seems that TMB-8-induced hyperreactivity 
occurs by a mechanism independent of calcium immobilisation.
Despite its potentiating effects on halothane-, caffeine- and 
succinylcholine-induced contractures, TMB-8 inhibited KCl-induced 
depolarising contractures in MH skeletal muscle. The differential 
effects of TMB-8 on KC1- and succinylcholine-induced contractures 
supports the contention that in MH skeletal muscle the succinylcholine 
contracture occurs by a mechanism independent of membrane depolarisation 
(Moulds, 1978). TMB-8 therefore represents a useful tool to differentially 
probe the mechanisms underlying abnormal drug-induced contractures in MH 
skeletal muscle.
The final chapter examines platelet function in MH and the results 
presented confirm that platelet abnormalities occur in some MH susceptible
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individuals. Previous work had shown that abnormal platelet aggregation 
is found in a number of MH susceptible individuals (Isaacs, 1978; Zsigmond 
et al. , 1978). In these studies when abnormal platelet function occurred 
it was always associated with decreased platelet reactivity. This 
contrasts with the hyperreactivity that is found in MH skeletal muscle. 
Furthermore, it indicates that although there are many similarities between 
excitation-secretion coupling in the platelet and excitation-contraction 
coupling in skeletal muscle (Day and Holmsen, 1971; Barnhart, 1978) 
there are important differences. The inability of the excitation- 
contraction coupling inhibitor dantrolene sodium to modify platelet 
aggregatory responses to collagen, adrenaline or ADP in normal and MH 
individuals emphasises such differences (J. Sullivan, N.G. Ardlie and 
M.A. Denborough, unpublished results).
In all the individuals screened in this study MH was suspected 
either because they were relatives of MH susceptible individuals or because 
they developed "complications" during anaesthesia. Therefore, although the 
in vitro pharmacological assessment of drug induced contractures classified 
these individuals as ’’normal", the possibility canot be excluded that the 
high incidence of abnormal platelet function in these "normal" individuals 
reflects incomplete penetrance and variable expression of the MH trait.
These observations on abnormal platelet aggregation in a number of 
MH susceptible individuals support the hypothesis that the basic abnormality 
in MH is membrane localised and that it is expressed in a number of different 
cell types. The different types of aggregatory responses found in this 
and other studies (Isaacs, 1978; Zsigmound et al. , 1978) probably reflect 
the heterogenous nature of the syndrome. The occurrence of normal platelet 
responses in individuals unambiguously identified as being MH susceptible,
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together with the occurrence of abnormal responses in normal individuals 
on a variety of medication (Barrer and Ellison, 1977; Verstraete, 1978) j 
shows that platelet function tests alone cannot be used to identify 
susceptibility to MH.
8.3 SUMMARY
A variety of evidence favours the E-C coupling process as the 
primary site of the abnormality predisposing to MH. At the molecular level 
E-C coupling occurs within the triad, thereby implying that in MH triad 
structure and/or function is abnormal. The inability to detect structural 
or functional abnormalities in microsomal membrane fractions is consistent 
with such a specific localisation of the abnormality. The effects of 
temperature and TMB-8 on drug-induced contractures in MH skeletal muscle 
are also consistent with a triadic site for the primary skeletal muscle 
abnormality. This implies that a more suitable membrane fractionation 
scheme, designed to isolate an enriched triadic preparation, might lead 
to a more precise identification of the molecular nature of the skeletal 
muscle membrane abnormality predisposing to MH.
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